<SEC-DOCUMENT>0000947871-22-001014.txt : 20220926
<SEC-HEADER>0000947871-22-001014.hdr.sgml : 20220926
<ACCEPTANCE-DATETIME>20220926160535
ACCESSION NUMBER:		0000947871-22-001014
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20220926
DATE AS OF CHANGE:		20220926

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEye, Inc.
		CENTRAL INDEX KEY:			0001818644
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		IRS NUMBER:				371827430
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-264727
		FILM NUMBER:		221265701

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLACE, SUITE 200
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568
		BUSINESS PHONE:		925-400-4366

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLACE, SUITE 200
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CF Finance Acquisition Corp. III
		DATE OF NAME CHANGE:	20200717
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>ss1352954_posam.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-size: 10pt"><A HREF="#TableOfContents">Table of Contents</A></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on September 26, 2022 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Registration No.&nbsp;333-264727&nbsp;&nbsp;&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: right"></P>





<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>UNITED STATES </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>WASHINGTON, D.C. 20549 </B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>POST-EFFECTIVE AMENDMENT NO. 1 TO </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>FORM S-1 ON FORM S-3 </B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REGISTRATION STATEMENT </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>UNDER </I></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><I>THE SECURITIES ACT OF 1933 </I></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>AEYE, INC. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>(Exact name of registrant as specified in its charter)
</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; width: 34%"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; width: 33%"><FONT STYLE="font-size: 10pt"><B>3714</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center; width: 33%"><FONT STYLE="font-size: 10pt"><B>37-1827430</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>(State or other jurisdiction of</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>(Primary Standard Industrial</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>(I.R.S. Employer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>incorporation or organization)</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>Classification Code Number)</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt"><B>Identification No.)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>One Park Place, Suite 200 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Dublin, CA 94568 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(925) 400-4366 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>(Address, including zip code, and telephone number,
including area code, of registrant&#8217;s principal executive offices) </B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>Blair LaCorte </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Chief Executive Officer </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>One Park Place, Suite 200 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Dublin, CA 94568 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(925) 400-4366 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Name, address, including zip code, and telephone
number, including area code, of agent for service) </B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B><I>Copies to: </I></B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Christopher M. Forrester </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Shearman&nbsp;&amp; Sterling LLP </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1460 El Camino Real, Floor 2 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Menlo Park, CA 94025 </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Tel: (650) 838-3600 </B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0; text-align: center"><B>Approximate date of commencement of proposed
sale to the public: </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>From time to time after this registration statement
becomes effective, as determined by the Selling Stockholder. </B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection
with dividend or interest reinvestment plans, check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective
registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If this Form is a registration statement pursuant to General Instruction
I.D. a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the
Securities Act, check the following box.&nbsp;&nbsp;<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If this Form is a post-effective amendment to a registration statement
filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule
413(b) under the Securities Act, check the following box. <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
&#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth
company&#8221; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 15%">&nbsp;</TD>
    <TD STYLE="width: 62%">&nbsp;</TD>
    <TD STYLE="width: 22%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 8pt">&#9744;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">Accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 8pt">&#9744;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">Non-accelerated filer</FONT></TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 8pt">&#9746;</FONT></TD>
    <TD><FONT STYLE="font-size: 8pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 8pt">&#9746;</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 8pt">Emerging&nbsp;growth&nbsp;company</FONT></TD>
    <TD><FONT STYLE="font-family: Segoe UI Symbol,sans-serif; font-size: 8pt">&#9746;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 3pt 0 0"><B>The Registrant hereby amends this Registration Statement on such
date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states
that this Registration Statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933,
as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting
pursuant to said Section&nbsp;8(a), may determine.</B></P>





<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-indent: 167.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">On May 6, 2022, the registrant filed a registration
statement on Form S-1 (Registration No. 333- 264727), which was declared effective by the U.S. Securities and Exchange Commission (the
&#8220;SEC&#8221;) on May 16, 2022 (as amended, the &#8220;Registration Statement&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">This Post-Effective Amendment No. 1 to Form S-1 on
Form S-3 (&#8220;Post-Effective Amendment No. 1&#8221;) is being filed by the Company to convert the registration statement on Form S-1
into a registration statement on Form S-3. Since the original effective date of the Registration Statement, the Selling Stockholder has
sold a certain number of shares registered hereunder. The share information contained in this Post-Effective Amendment No.&nbsp;1, including
the table of Selling Stockholder, has not been updated to reflect such changes and such information is presented herein without giving
effect to such sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">No additional securities are being registered under
this Post-Effective Amendment No. 1. All applicable registration fees were paid at the time of the original filing of the Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial Narrow, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #FF4338"><B>The information in this prospectus
is not complete and may be changed. The Selling Stockholder may not sell these securities until the registration statement filed with
the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting
an offer to buy these securities in any state where the offer or sale is not permitted. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #FF4338"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #FF4338"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #FF4338"><B>Subject to Completion, dated September
26, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><B>PROSPECTUS </B></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>AEYE, INC. </B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 12pt 0 4pt; text-align: center"><B>Up to 30,865,419&nbsp;Shares of Common Stock
</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus relates to the offer and resale of up to 30,865,419&nbsp;shares
of common stock of AEye, Inc. (the &#8220;Common Stock&#8221;) by Tumim Stone Capital LLC (the &#8220;Selling Stockholder&#8221; or &#8220;Tumim&#8221;).
The shares of Common Stock being offered by Tumim have been and may be issued pursuant to the purchase agreement dated December&nbsp;8,
2021 that we entered into with Tumim (the &#8220;Purchase Agreement&#8221;). We are not selling any securities under this prospectus and
will not receive any of the proceeds from the sale of our Common Stock by Tumim. However, we may receive up to $125.0&nbsp;million in
aggregate gross proceeds from sales of our Common Stock to Tumim that we may make under the Purchase Agreement from time to time after
the date of this prospectus. On December&nbsp;8, 2021, we issued 302,634 shares of our Common Stock (the &#8220;Commitment Shares&#8221;),
to Tumim as consideration for its irrevocable commitment to purchase shares of our Common Stock under the Purchase Agreement. See the
sections entitled &#8220;The Tumim Transaction&#8221; for a description of the transaction contemplated by the Purchase Agreement and
&#8220;Selling Stockholder&#8221; for additional information regarding Tumim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim may sell the shares of our Common Stock included in this prospectus
in a number of different ways and at varying prices. We provide more information about how Tumim may sell the shares in the section entitled
&#8220;Plan of Distribution.&#8221; Tumim is an &#8220;underwriter&#8221; within the meaning of Section&nbsp;2(a)(11) of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim will pay all sales and brokerage commissions and similar expenses
in connection with the offer and resale of the Common Stock by Tumim pursuant to this prospectus. We will pay the expenses (except sales
and brokerage commissions and similar expenses) incurred in registering under the Securities Act the offer and resale of the shares included
in this prospectus by Tumim, including legal and accounting fees. See &#8220;Plan of Distribution.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We are an &#8220;emerging growth company&#8221; as defined in Section&nbsp;2(a)
of the Securities Act, and are subject to reduced public company reporting requirements. This prospectus complies with the requirements
that apply to an issuer that is an emerging growth company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">Our Common Stock is listed on The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;)
under the symbols &#8220;LIDR&#8221;. On September 19, 2022, the closing price of our Common Stock was $1.31 per share.</P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Our business and investment in our Common Stock involve significant
risks. These risks are described in the section titled &#8220;<I><A HREF="#RISKFACTORS">Risk Factors</A></I>&#8221; beginning on page 8 of this prospectus. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt"><B>Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any
representation to the contrary is a criminal offense. </B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 15%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2022. </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-align: center"><B><A NAME="TableOfContents"></A>Table of Contents</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 5.4pt; text-align: right"><B>Page</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#ABOUTTHISPROSPECTUS">ABOUT THIS PROSPECTUS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#CAUTIONARYNOTE">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#PROSPECTUSSUMMARY">PROSPECTUS SUMMARY</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#THEOFFERING">THE OFFERING</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#RISKFACTORS">RISK FACTORS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#THETUMIMTRANSACTION">THE TUMIM TRANSACTION</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">11</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#USEOFPROCEEDS">USE OF PROCEEDS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#SELLINGSTOCKHOLDERS">SELLING STOCKHOLDERS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#DESCRIPTIONOFOURSECURITIES">DESCRIPTION OF OUR SECURITIES</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#PLANOFDISTRIBUTION">PLAN OF DISTRIBUTION</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">26</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#LEGALMATTERS">LEGAL MATTERS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">28</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#EXPERTS">EXPERTS</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">28</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#MOREINFORMATION">WHERE YOU CAN FIND MORE INFORMATION</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">29</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt"><A HREF="#INFORMATIONINCORPORATEDBYREF">INFORMATION INCORPORATED BY REFERENCE</A></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 5pt; padding-left: 5.4pt; text-align: right">30</TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="ABOUTTHISPROSPECTUS" TITLE="ABOUT THIS PROSPECTUS"></A>ABOUT THIS PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus is part of a registration statement that we filed
with the U.S. Securities and Exchange Commission, or the SEC, using a &#8220;shelf&#8221; registration process. We are not selling any
securities under this prospectus and will not receive any of the proceeds from the sale of our Common Stock by the Selling Stockholder,
although we will receive proceeds from sales of our Common Stock to Tumim that we may make pursuant to the Purchase Agreement, as described
in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We may also file a prospectus supplement or post-effective amendment
to the registration statement of which this prospectus forms a part that may contain material information relating to these offerings.
The prospectus supplement or post-effective amendment may also add, update, or change information contained in this prospectus with respect
to that offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or
post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any
securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together
with the additional information described under the heading &#8220;<I>Where You Can Find More Information</I>&#8221; and &#8220;<I>Information
Incorporated by Reference.</I>&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Neither we nor the Selling Stockholder have authorized anyone to
provide you with any information or to make any representations other than those contained in or incorporated by reference into this prospectus,
any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred you.
We and the Selling Stockholder take no responsibility for and can provide no assurance as to the reliability of any other information
that others may give you. The Selling Stockholder will not make an offer to sell these securities in any jurisdiction where the offer
or sale is not permitted. You should assume that the information appearing in this prospectus, any post-effective amendment and any applicable
prospectus supplement to this prospectus is accurate only as of the date on its respective cover. Our business, financial condition, results
of operations and prospects may have changed since those dates. This prospectus contains, and any post-effective amendment or any prospectus
supplement may contain, market data and industry statistics and forecasts that are based on independent industry publications and other
publicly available information. We believe this information is reliable as of the applicable date of its publication, however, we have
not independently verified the accuracy or completeness of the information included in or assumptions relied on in these third-party publications.
In addition, the market and industry data and forecasts that may be included in or incorporated by reference into this prospectus, any
post-effective amendment or any prospectus supplement may involve estimates, assumptions and other risks and uncertainties and are subject
to change based on various factors, including those discussed under the heading &#8220;<I>Risk Factors</I>&#8221; contained in this prospectus,
any post-effective amendment and the applicable prospectus supplement. Accordingly, investors should not place undue reliance on this
information.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-size: 10pt">We own or have rights to trademarks,
trade names and service marks that we use in connection with the operation of our business. In addition, our name, logos and website name
and address are our trademarks or service marks. Solely for convenience, in some cases, the trademarks, trade names and service marks
referred to in this prospectus are listed without the applicable </FONT><FONT STYLE="font-size: 8.5pt"><SUP>&reg;</SUP></FONT><FONT STYLE="font-size: 10pt">,
</FONT><FONT STYLE="font-size: 8.5pt"><SUP>&#8482;</SUP></FONT> <FONT STYLE="font-size: 10pt">and SM symbols, but we will assert, to the
fullest extent under applicable law, our rights to these trademarks, trade names and service marks. Other trademarks, trade names and
service marks appearing in this prospectus are the property of their respective owners. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">On February&nbsp;17, 2021, AEye Technologies, Inc., then known as
AEye, Inc. (&#8220;AEye Technologies&#8221;), entered into the Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with
CF Finance Acquisition Corp. III, a Delaware corporation (&#8220;CF III&#8221;), now known as AEye, Inc., and Meliora Merger Sub, Inc.,
a Delaware corporation and a wholly owned subsidiary of CF III (&#8220;Merger Sub&#8221;). Based on CF III&#8217;s business activities,
it was a &#8220;shell company&#8221; as defined under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).
On August&nbsp;16, 2021 (the &#8220;Closing Date&#8221;), CF III closed the business combination (the &#8220;Merger,&#8221; and together
with the other transactions contemplated by the Merger Agreement, the &#8220;Transactions&#8221;) pursuant to the Merger Agreement, and
Merger Sub was merged with and into AEye Technologies with AEye Technologies surviving the merger as a wholly owned subsidiary of CF III.
On the Closing Date, and in connection with the closing of the Transactions (the &#8220;Closing&#8221;), CF III changed its name to AEye,
Inc. Unless otherwise stated or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221;,
&#8220;AEye&#8221;, &#8220;Company&#8221;, and &#8220;post-combination entity&#8221; refer to AEye, Inc. and its subsidiaries following
the consummation of the Merger or to AEye Technologies and its subsidiaries prior to the consummation of the Merger.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="CAUTIONARYNOTE" TITLE="CAUTIONARY NOTE"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus, any accompanying prospectus supplement and the
documents incorporated by reference herein contain forward-looking statements. All statements other than statements of historical facts
contained in this prospectus, any accompanying prospectus supplement and the documents incorporated by reference herein, including statements
concerning possible or assumed future actions, business strategies, events or results of operations, and any statements that refer to
projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking
statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results,
performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the
forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">In some cases, you can identify forward-looking statements by terms
such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221;
&#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221;
&#8220;predict,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions.
These forward-looking statements are only predictions. We have based these forward-looking statements largely on our current expectations
and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations.
The forward-looking statements in this prospectus, any accompanying prospectus supplement and the documents incorporated by reference
herein speak only as of the date of this prospectus, any accompanying prospectus supplement, and the documents incorporated by reference
herein, as applicable. These forward-looking statements are subject to a number of important factors that could cause actual results to
differ materially from those in the forward-looking statements, including the risks, uncertainties and assumptions described under the
section in this prospectus titled &#8220;<I>Risk Factors</I>.&#8221; These forward-looking statements are subject to numerous risks, including,
without limitation, the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our product development timeline and expected start of production;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the implementation, market acceptance and success of our business model;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our ability to scale in a cost-effective manner;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>developments and projections relating to our competitors and industry;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the impact of health epidemics, including the COVID-19 pandemic, on our business and the actions we may take in response thereto;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the effect of global events, such as the Russia&#8217;s invasion of Ukraine, on the U.S. and global economies, our business, our employees,
results of operations, financial condition, demand for our products and partners&#8217; businesses;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>expectations regarding the time during which we will be an emerging growth company under the JOBS Act;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our future capital requirements and sources and uses of cash;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our ability to obtain funding for our operations;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our business, expansion plans and opportunities; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the outcome of any known and unknown litigation and regulatory proceedings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Because forward-looking statements are inherently subject to risks
and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these
forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may
not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover,
we operate in an evolving environment. Some of these risks and uncertainties may in the future be amplified by the COVID-19 pandemic.
Additionally, new risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk
factors and uncertainties. As a result of these factors, the forward-looking statements in this prospectus, any accompanying prospectus
supplement and the documents incorporated by reference herein may not prove to be accurate. Except as required by applicable law, we do
not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future
events, changed circumstances, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">You should read this prospectus, any accompanying prospectus supplement
and the documents incorporated by reference herein completely and with the understanding that our actual future results may be materially
different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border: Black 1pt solid; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="padding-right: 5pt; padding-left: 5pt"><P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><B><A NAME="PROSPECTUSSUMMARY" TITLE="PROSPECTUS SUMMARY"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This summary highlights, and is qualified in its entirety by, the
more detailed information and financial statements included elsewhere in this prospectus. This summary does not contain all of the information
that may be important to you in making your investment decision. You should read this entire prospectus carefully, especially the &#8220;Risk
Factors&#8221; section beginning on page&nbsp;8 and our consolidated financial statements and the related notes appearing at the end of
this prospectus, before deciding to invest in our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Overview </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 0"><FONT STYLE="font-size: 10pt">AEye is a provider of high-performance,
active lidar systems technology for vehicle autonomy, advanced driver-assistance systems, (&#8220;ADAS&#8221;), and robotic vision applications.
With a sophisticated workforce of leaders and researchers, AEye has developed an artificial intelligence technology that enables adaptive
&#8220;intelligent sensing,&#8221; differentiating AEye in the marketplace from its competition. Our proprietary software-definable 4Sight</FONT><FONT STYLE="font-size: 8.5pt"><SUP>TM</SUP></FONT>
<FONT STYLE="font-size: 10pt">Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera,
and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate,
and more reliable perception of the surroundings. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">AEye was founded in 2013 by Luis Dussan, AEye&#8217;s Chief Technology
Officer, to create a deterministic AI-driven sensing system that performs better than the human eye and visual cortex. Mr.&nbsp;Dussan&#8217;s
experience developing mission-critical targeting systems for fighter jets and ground troops on behalf of the U.S. military provided him
with the background to develop a differentiated approach to visual sensing. While traditional sensing systems passively collect data,
our active 4SightTM Intelligent Sensing Platform leverages principles from automated targeting systems and biomimicry to scan the environment,
while intelligently focusing on what matters in order to enable safer, smarter, and faster decisions in complex scenarios. From its inception,
AEye&#8217;s culture drew from esteemed scientists and electro-optics engineers from the National Aeronautics and Space Administration,
or NASA, Lockheed Martin Corporation, Northrop Grumman Corporation, the U.S. Air Force, and the Defense Advanced Research Projects Agency,
or DARPA, to create the highest performing sensing and perception system for the most challenging situations, ensuring the highest levels
of safety for autonomous driving.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"><FONT STYLE="font-size: 10pt">As a result, our adaptive lidar is
designed to enable higher levels of autonomy and functionality &#8212; SAE Levels 2 through 5 &#8212; with the goal of optimizing performance,
power, and reducing cost. Our 4Sight</FONT><FONT STYLE="font-size: 8.5pt"><SUP>TM</SUP></FONT> <FONT STYLE="font-size: 10pt">Intelligent
Sensing Platform is software-definable, and network-optimized, and leverages deterministic artificial intelligence at the edge. We have
made substantial investments in our R&amp;D processes and deliver value to our customers through a combination of sales and direct channels.
We perform the majority of our R&amp;D activities in our 56,549 square foot corporate headquarters in Dublin, California. Our modular
design facilitates product hardware updates as technologies evolve, and its small size and modest heat dissipation enable very flexible
placement options on the interior or exterior of a vehicle. 4Sight also leverages a common architecture to create application-specific
products across the Automotive, Mobility and Industrial markets. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We expect to enable accelerated adoption of lidar across many markets
and have partnered with leading Tier 1 automobile suppliers to achieve this mission. The main markets for lidar, including Automotive,
Industrial, and Mobility, are projected to see significant growth in both the near and long term. We believe this expected growth will
allow AEye to achieve greater market share as well as pursue specialization opportunities like highway autonomous driving applications
that benefit from our products. We expect that lidar will be a required sensing solution across many end markets, and we intend to be
the leading solutions provider in these spaces.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Background </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">We were originally known as CF III. On August&nbsp;16, 2021, CF III
consummated the Merger with AEye Technologies pursuant to the Merger Agreement. In connection with the Closing of the Merger, CF III changed
its name to AEye, Inc. The Merger was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting,
CF III was treated as the &#8220;accounting acquiree&#8221; and AEye Technologies as the &#8220;accounting acquirer&#8221; for financial
reporting purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">At the effective time of the Merger (the &#8220;Effective Time&#8221;),
by virtue of the Merger and without any action on the part of CF III, Merger Sub, AEye Technologies or the holders of any of our or AEye
Technologies&#8217; securities:</P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; width: 10%; vertical-align: top">&#8226;</TD>
  <TD STYLE="width: 90%">Merger Sub merged with and into AEye Technologies, with AEye Technologies surviving as a wholly-owned subsidiary of the Company;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>each share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time was automatically converted
into an equal number of shares of common stock of validly issued, fully paid and nonassessable shares of common stock of AEye Technologies,
which shares constitute the only outstanding shares of capital stock of AEye Technologies held by us;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border: Black 1pt solid; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top; width: 10%">&nbsp;</TD>
  <TD STYLE="width: 90%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all issued and outstanding shares of AEye Technologies&rsquo; capital stock
(other than shares held by us, CF Finance Holdings III, LLC (the &ldquo;Sponsor&rdquo;) or held in treasury) converted into an aggregate
of 122,509,667 shares of Common Stock.</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all shares of AEye Technologies&rsquo; capital stock held in treasury were
canceled without any conversion thereof;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all of the outstanding options of AEye Technologies to acquire AEye Technologies&rsquo;
common stock were assumed by the Company and converted into options to acquire an aggregate of 29,415,292 shares of Common Stock;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all of the outstanding restricted stock units (&ldquo;RSUs&rdquo;) of AEye
Technologies to acquire AEye Technologies&rsquo; common stock were assumed by the Company and converted into RSUs to acquire an aggregate
of 1,724,283 shares of Common Stock;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all of the 5,750,000 outstanding shares of CF III&rsquo;s Class&nbsp;B
common stock, par value $0.0001 per share, held by the Sponsor and the former independent directors of CF III converted into an aggregate
of 5,750,000 shares of Common Stock;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all of the 500,000 private placement units held by the Sponsor were separated,
pursuant to their terms, into 500,000 shares of Common Stock and 166,666 Warrants; and</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&#8226;</TD>
  <TD>all of the remaining outstanding Company units were separated, pursuant
to their terms, into one share of Common Stock and one-third (1/3) of one Warrant (and CF III&rsquo;s units ceased trading on Nasdaq).</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2" STYLE="padding-right: 5pt; text-align: left; vertical-align: top; padding-left: 5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">In connection with the execution of the Merger Agreement, CF III
entered into subscription agreements with certain parties subscribing for shares of CF III&rsquo;s common stock, par value $0.0001 per
share (&ldquo;CF III Common Stock,&rdquo; and such parties, the &ldquo;Subscribers&rdquo;), pursuant to which the Subscribers agreed to
purchase, and CF III agreed to sell to the Subscribers, an aggregate of up to 22,500,000 shares of CF III Common Stock, for a purchase
price of $10.00 per share and at an aggregate purchase price of up to $225&nbsp;million. Immediately prior to the closing of the Merger,
we issued and sold 22,000,000 shares of our Common Stock to the Subscribers for aggregate gross proceeds to us of $220&nbsp;million (the
&ldquo;PIPE Investment&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The rights of holders of our Common Stock are governed by our Second
Amended and Restated Certificate of Incorporation (the &ldquo;Amended Charter&rdquo;), our Amended and Restated Bylaws (the &ldquo;Amended
Bylaws&rdquo;), and the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;). See the section titled &ldquo;<I>Description of Our
Securities</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Corporate Information </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">CF III was incorporated in the State of Delaware in March 2016 for
the purpose of effecting a transaction such as the Merger and completed its initial public offering (the &ldquo;IPO&rdquo;) in November
2020. In August 2021, Merger Sub merged with and into AEye Technologies, with AEye Technologies surviving the merger as a wholly owned
subsidiary of CF III. In connection with the Merger, we changed our name to AEye, Inc. Our principal executive offices are located at
One Park Place, Suite 200, Dublin, CA 94568. Our telephone number is (925) 400-4366. Our website address is <I>www.aeye.ai</I>. Information
contained on our website or connected thereto does not constitute part of, and is not incorporated by reference into, this prospectus
or the registration statement of which it forms a part.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Implications of Being an Emerging Growth Company and a Smaller Reporting
Company </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">We are an emerging growth company as defined in the Jumpstart Our
Business Startups Act of 2012 (the &ldquo;JOBS Act&rdquo;). We will remain an emerging growth company under the JOBS Act until the earliest
of (a)&nbsp;the last day of our first fiscal year following the fifth anniversary of CF III&rsquo;s IPO, (b)&nbsp;the last date of our
fiscal year in which we have total annual gross revenue of at least $1.07&nbsp;billion, (c)&nbsp;the date on which we are deemed to be
a &ldquo;large accelerated filer&rdquo; under the rules of the SEC with at least $700.0&nbsp;million of outstanding securities held by
non-affiliates, or (d)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in non-convertible debt securities during the
previous three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We are also a &ldquo;smaller reporting company&rdquo; as defined
in the Securities and Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company.
We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage
of these scaled disclosures for so long as the market value of our Common Stock held by non-affiliates is less than $250.0&nbsp;million
measured on the last business day of our second fiscal quarter, or our annual revenue is less than $100.0&nbsp;million during the most
recently completed fiscal year and the market value of our Common Stock held by non-affiliates is less than $700.0&nbsp;million measured
on the last business day of our second fiscal quarter.</P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border: Black 1pt solid; padding-right: 5pt; width: 100%; padding-left: 5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">As a result, the information in this prospectus, any accompanying
prospectus supplement or the documents incorporated by reference herein that we provide to our investors in the future may be different
than what you might receive from other public reporting companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>The Tumim Transaction </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">On December 8, 2021, we entered into the Purchase Agreement with
Tumim, pursuant to which Tumim has committed to purchase up to $125 million of Common Stock (the &#8220;Total Commitment&#8221;), at our
direction from time to time after the date of this prospectus, subject to the satisfaction of the conditions in the Purchase Agreement.
Also, we entered into a registration rights agreement with Tumim (the &#8220;Registration Rights Agreement&#8221;), pursuant to which
pursuant to which we agreed to file with the SEC the registration statement that includes this prospectus to register for resale under
the Securities Act, the shares of our Common Stock that have been and may be issued to Tumim under the Purchase Agreement. Pursuant to
the terms of the Purchase Agreement, at the time we signed the Purchase Agreement and the Registration Rights Agreement, we issued 302,634
Commitment Shares to Tumim as consideration for its irrevocable commitment to purchase shares of our Common Stock under the Purchase Agreement.
The 302,634 Commitment Shares are also covered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Under the terms and subject to the conditions of the Purchase Agreement,
we have the right, but not the obligation, to sell to Tumim, and Tumim is obligated to purchase, up to $125.0 million of our Common Stock.
Such sales of Common Stock by us, if any, will be subject to certain limitations, and may occur from time-to-time in our sole discretion,
over the period commencing once certain customary conditions are satisfied, including the filing and securing effectiveness of this resale
registration statement with the SEC with respect to the shares to be sold to Tumim under the Purchase Agreement, and ending on the first
day of the month following the 36-month anniversary of the closing date of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Shares will be issued from us to Tumim at a 3.85% discount to the
one-day forward volume-weighted average price from the date a purchase notice is issued, plus an additional fee of 2% payable to the placement
agent (to a cumulative maximum of $2 million) with respect to the issuance and sale of the shares pursuant to the Purchase Agreement.
There are no upper limits on the price per share that Tumim must pay for shares of the Common Stock. Actual sales of shares of Common
Stock to Tumim will depend on a variety of factors to be determined by us from time-to-time, including, among other things, market conditions,
the trading price of our Common Stock, and determinations by us as to the appropriate sources of funding for us and our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Under the applicable Nasdaq rules, we may not issue to Tumim under the
Purchase Agreement more than</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">30,865,419 shares of its Common Stock, which number of shares is equal
to 19.99% of the shares of the Company&#8217;s Common Stock outstanding (the &#8220;Exchange Cap&#8221;) as of the date of the Purchase
Agreement, unless (i) we obtains stockholder approval to issue shares of its Common Stock in excess of the Exchange Cap in accordance
with applicable Nasdaq rules, or (ii) the average purchase price per share paid by Tumim for all shares of the our Common Stock, if any,
that we elect to sell to Tumim under the Purchase Agreement equals or exceeds the lower of (a) the Nasdaq official closing price for our
Common Stock immediately preceding the execution of the Purchase Agreement, and (b) the arithmetic average of the five Nasdaq official
closing prices for the Common Stock during the 5-trading day period immediately preceding the execution of the Purchase Agreement, as
adjusted so that the Exchange Cap will not apply to issuances of Common Stock under the Purchase Agreement under applicable Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Moreover, we may not issue or sell any shares of our Common Stock
to Tumim under the Purchase Agreement which, when aggregated with all other shares of our Common Stock then beneficially owned by Tumim
and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule&nbsp;13d-3 promulgated
thereunder), would result in Tumim beneficially owning more than 9.99% of the outstanding shares of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The net proceeds under the Purchase Agreement to us will depend
on the frequency and prices at which we sell shares of our stock to Tumim. We expect that any proceeds received by us from such sales
to Tumim will be used for working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The Purchase Agreement will automatically terminate upon the earliest
of (i) the expiration of the 36-month period following the date of execution of the Purchase Agreement, (ii) Tumim&#8217;s purchase of
the Total Commitment worth of Common Stock under the Purchase Agreement, or (iii) the occurrence of certain other events set forth in
the Purchase Agreement. We have the right to terminate the Purchase Agreement at any time after Commencement, at no cost or penalty, upon
one trading day&#8217;s prior written notice to Tumim. Neither we nor Tumim may assign or transfer its rights and obligations under the
Purchase Agreement, and no provision of the Purchase Agreement or the Registration Rights Agreement may be modified or waived by the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">There are no restrictions on future financings, rights of first
refusal, participation rights, penalties or liquidated damages in the Purchase Agreement or Registration Rights Agreement other than a
prohibition on entering into a &#8220;Variable Rate Transaction,&#8221; as defined in the Purchase Agreement, and as more specifically
described in the section of this prospectus entitled &#8220;The Tumim Transaction.&#8221; Tumim has agreed not to cause, or engage in
any manner whatsoever, any direct or indirect short selling or hedging of the common stock.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P> </TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="padding-right: 5pt; border: Black 1pt solid; width: 100%; padding-left: 5pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                          do not know what the purchase price for our Common Stock will be and therefore cannot be certain as to the
                          number of shares we might issue to Tumim under the Purchase Agreement. If all of the 30,865,419 shares offered
                          by Tumim for resale under this prospectus were issued and outstanding as of the date hereof, such shares would
                          represent approximately 16.44% of the total number of shares of our Common Stock outstanding as of April 29,
                          2022. The number of shares ultimately offered for resale by Tumim is dependent upon the number of shares we
                          may elect to sell to Tumim under the Purchase Agreement from and after the Commencement Date.</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
                          <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 38%; padding-bottom: 1pt; padding-left: 12.25pt; text-indent: -12.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 62%; padding-left: 0.1in">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="padding-left: 0.1in; text-align: center"><FONT STYLE="font-size: 10pt"><B><A NAME="THEOFFERING" TITLE="THE OFFERING"></A>THE OFFERING</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.25pt; text-indent: -12.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-right: 5pt; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">Shares of Common Stock offered by the Selling Stockholder (1)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">302,634 Commitment Shares issued to Tumim upon execution of the Purchase Agreement. We have not and will not receive any cash proceeds from the issuance of the Commitment Shares.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.25pt; text-indent: -12.25pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">Up to 30,562,785 shares (the &ldquo;Purchase Shares&rdquo;) we may sell to Tumim under the Purchase Agreement from time to time after the Commencement Date (as defined below). The actual number of Purchase Shares issued will vary depending upon the actual sales prices to Tumim pursuant to the Purchase Agreement.</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">Shares of Common Stock outstanding</FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">160,800,188 shares (as of September 19, 2022). </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.25pt; text-indent: -12.25pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">Use of proceeds</FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">We will not receive any proceeds from the resale of shares by the Selling Stockholder. We may receive up to $125.0&nbsp;million in aggregate gross proceeds under the Purchase Agreement from sales of our Common Stock that we elect to make to Tumim pursuant to the Purchase Agreement, if any, from time to time in our sole discretion, from and after the Commencement Date. See &ldquo;<I>Use of Proceeds</I>&rdquo; on page&nbsp;18 for additional information. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.2pt; text-indent: -12.2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">Risk factors</FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">You should carefully read the &ldquo;<I>Risk Factors</I>&rdquo; beginning
    on page&nbsp;8 and the other information included in this prospectus for a discussion of factors you should consider carefully before
    deciding to invest in our Common Stock. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.2pt; text-indent: -12.2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">Nasdaq&nbsp;symbol&nbsp;for&nbsp;our&nbsp;Common&nbsp;Stock</FONT></TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-size: 10pt">&ldquo;LIDR&rdquo; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; padding-left: 12.2pt; text-indent: -12.2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 4%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">(1)</FONT></TD>
    <TD STYLE="width: 92%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt; background-color: white">Since the original Effective Date of our Registration Statement, a certain number of shares of common stock registered hereunder have been sold. The total of </FONT><FONT STYLE="font-size: 8pt">30,865,419 <FONT STYLE="background-color: white">shares referenced throughout this filing has not been updated to reflect such sales and exercises. Reference is made to note (2) below for specific details on the number of shares of common stock registered hereunder that have been sold.</FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-top: 12pt; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 8pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 12pt 0 0">The number of shares of Common Stock to be outstanding excludes:</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;26,152,793 shares of Common Stock issuable upon the exercise
    of outstanding options granted under 2014 Plan or the 2016 Plan, with a&nbsp;weighted-average exercise price of $0.49 per share;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;10,733,388 shares of Common Stock available for future issuance
    under our 2021 Equity Incentive Plan;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;11,840,360 shares of Common Stock underlying restricted
    stock units, or RSUs, granted pursuant to our 2016 Plan or 2021 Equity Incentive Plan;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;7,833,322 shares of Common Stock issuable upon the exercise
    of outstanding public and private placement warrants to purchase Common Stock, with an exercise price of $11.50 per share (out of a total
    of 7,833,332 warrants issued, of which 10 warrants have been exercised as of the date of this filing);</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;29,852,785 purchase shares we may sell to Tumim Stone under
    that certain Common Stock Purchase Agreement from time to time (out of a total of 30,562,785 purchase shares, of which 710,000 have been
    sold as of September 19, 2022);</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&bull;&#9;&nbsp;&nbsp;&nbsp;&nbsp;30,367,892 shares of Common Stock issuable upon conversion
    of our senior secured convertible note due March 15, 2024 and 1,750,000 shares of Common Stock issuable upon the exercise of outstanding
    warrants to purchase Common Stock issued in connection therewith, with an exercise price of $3.50 per share.</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 6pt 0 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="RISKFACTORS" TITLE="RISK FACTORS"></A><B>RISK FACTORS</B></P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">Investing in any of our securities
involves significant risks. </FONT>Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed
above under &#8220;<I>Forward-Looking Statements</I>,&#8221; <FONT STYLE="background-color: white">you should carefully consider the specific
risks set forth under the heading &#8220;Risk Factors&#8221; under Item 1A of Part I of our Annual Report on&nbsp;Form&nbsp;10-K&nbsp;filed
with the SEC, any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, and all other information contained or incorporated
by reference to this prospectus, as updated by our subsequent filings under the Exchange Act, and the risk factors and other information
contained in any applicable prospectus supplement and any applicable free writing prospectus before acquiring any of such securities.
If any of these risks actually occur, it may materially harm our business, financial condition, liquidity and results of operations. As
a result, the market price of our securities could decline, and you could lose all or part of your investment. Additionally, the risks
and uncertainties described in this prospectus, any prospectus supplement or any documents incorporated by reference herein are not the
only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that we currently believe to
be immaterial may become material and adversely affect our business. For more information, see &#8220;<I>Where You Can Find More Information</I>&#8221;
and &#8220;<I>Information Incorporated by Reference</I>.&#8221;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Risks Related to this Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><B><I>It is not possible to predict the actual number of shares we
will sell under the Purchase Agreement, or the actual gross proceeds resulting from those sales. We may not have access to the full amount
available under the Purchase Agreement with Tumim. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">On December&nbsp;8, 2021, we entered into the Purchase Agreement
with Tumim, pursuant to which Tumim has committed to purchase up to $125.0&nbsp;million in shares of our Common Stock, subject to certain
limitations and conditions set forth in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The shares of our Common Stock that may be issued under the Purchase
Agreement may be sold by us to Tumim at our discretion from time to time over an approximately 36-month period commencing on the closing
date of the Purchase Agreement, provided this registration statement covering the resale of shares of Common Stock that have been and
may be issued under the Purchase Agreement is declared effective by the SEC, a final prospectus in connection therewith is filed, and
the other conditions set forth in the Purchase Agreement are satisfied. We generally have the right to control the timing and amount of
any sales of our shares of our Common Stock to Tumim under the Purchase Agreement. Sales of our Common Stock to Tumim under the Purchase
Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Tumim all or
a portion of the shares of our Common Stock that may be available pursuant to the Purchase Agreement, or decide to not sell to Tumim any
shares of our Common Stock that may be available for us to sell to Tumim pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Because the purchase price per share to be paid by Tumim for the
shares of our Common Stock that we may elect to sell to Tumim under the Purchase Agreement will fluctuate based on the market prices of
our Common Stock during such purchase, it is not possible for us to predict, as of the date of this prospectus, the number of shares of
our Common Stock that we will sell to Tumim under the Purchase Agreement, the purchase price per share that Tumim will pay for shares
purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by Tumim under
the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Although the Purchase Agreement provides that we may sell up to
an aggregate of $125.0&nbsp;million of our Common Stock to Tumim, only 30,865,419 shares of our Common Stock are being registered for
resale by Tumim under the registration statement that includes this prospectus, consisting of the 302,634 Commitment Shares that we previously
issued to Tumim upon execution of the Purchase Agreement as consideration for its commitment to purchase our Common Stock under the Purchase
Agreement and up to 30,562,785&nbsp;Purchase Shares that we may elect to sell to Tumim, in our sole discretion, from time to time from
and after the Commencement Date under the Purchase Agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If we elect to sell to Tumim all of the Purchase Shares being registered
for resale under this prospectus that are available for sale by us to Tumim in purchases under the Purchase Agreement, depending on the
market prices of our Common Stock during such purchase made pursuant to the Purchase Agreement, the actual gross proceeds from the sale
of all such shares may be substantially less than the $125.0&nbsp;million (the &#8220;Total Commitment&#8221;) available to us under the
Purchase Agreement, which could materially adversely affect our liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If it becomes necessary for us to issue and sell to Tumim under
the Purchase Agreement more than 30,865,419 shares being registered for resale under the registration statement that includes this prospectus
in order to receive aggregate gross proceeds equal to the total commitment of an aggregate of $125.0&nbsp;million under the Purchase Agreement,
we must file with the SEC one or more additional registration statements to register under the Securities Act the resale by Tumim of any
such additional shares of our Common Stock we wish to sell from time to time under the Purchase Agreement, which the SEC must declare
effective. We will need to obtain stockholder approval to issue shares of our Common Stock in excess of the Exchange Cap under the Purchase
Agreement in accordance with the Nasdaq listing rules, unless the average per share purchase price paid by Tumim for all shares of our
Common Stock sold under the Purchase Agreement equals or exceeds $4.90, in which case, under the Nasdaq listing rules, the Exchange Cap
limitation will not apply to issuances and sales of our Common Stock under the Purchase Agreement, in each case, before we may elect to
sell any additional shares of our Common Stock to Tumim under the Purchase Agreement. In addition, Tumim will not be required to purchase
any shares of our Common Stock if such sale would result in Tumim&#8217;s beneficial ownership exceeding 9.99% of the then outstanding
shares of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">Any issuance and sale by us under the Purchase Agreement of a substantial
amount of shares of our Common Stock in addition to the 30,865,419 shares of our Common Stock being registered for resale by Tumim under
this prospectus could cause additional substantial dilution to our stockholders. The number of shares of our Common Stock ultimately offered
for resale by Tumim is dependent upon the number of shares of our Common Stock we ultimately sell to Tumim under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Our inability to access a portion or the full amount available under
the Purchase Agreement, in the absence of any other financing sources, could have a material adverse effect on our business. The extent
to which we rely on Tumim as a source of funding will depend on a number of factors including the prevailing market price of our Common
Stock and the extent to which we are able to secure working capital from other sources. If obtaining sufficient funding from Tumim were
to prove unavailable or prohibitively dilutive, we will need to secure another source of funding in order to satisfy our working capital
needs. Even if we were to receive all $125.0&nbsp;million in gross proceeds under the Purchase Agreement, we may still need additional
capital to fully implement our business, operating and development plans. Should the financing we require to sustain our working capital
needs be unavailable or prohibitively expensive when we require it, the consequences could be a material adverse effect on our business,
operating results, financial condition and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B><I>Investors who buy shares at different times will likely
pay different prices. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Pursuant to the Purchase Agreement, we will have discretion, subject
to market demand, to vary the timing, prices, and numbers of shares sold to Tumim. If and when we do elect to sell shares of our Common
Stock to Tumim under the Purchase Agreement, after Tumim has acquired such shares, Tumim may resell all or a portion of such shares at
any time or from time to time in its discretion and at different prices. As a result, investors who purchase shares from Tumim at different
times will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial
dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase
from Tumim as a result of future sales made by us to Tumim at prices lower than the prices such investors paid for their shares.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B><I>We may require additional financing to sustain our operations and
without it we will not be able to continue operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Subject to the terms and conditions the Purchase Agreement, we may,
at our discretion, direct Tumim to purchase up to an aggregate of up to $125.0&nbsp;million of our Common Stock under the Purchase Agreement
from time-to-time over an approximately 36-month period beginning on the closing date of the Purchase Agreement, provided that a registration
statement covering the resale of shares of Common Stock that have been and may be issued under the Purchase Agreement is declared effective
by the SEC, a final prospectus in connection therewith is filed, and the other conditions set forth in the Purchase Agreement are satisfied.
Although the Purchase Agreement provide that we may sell up to an aggregate of $125.0&nbsp;million of our Common Stock to Tumim, only
30,562,785 shares of our Common Stock that we may elect to sell to Tumim under the Purchase Agreement are being registered. The purchase
price per share for the shares of our Common Stock that we may elect to sell to Tumim under the Purchase Agreement will fluctuate based
on the market prices of our Common Stock during such purchase made pursuant to the Purchase Agreement. Accordingly, it is not currently
possible to predict the number of shares that will be sold to Tumim, the actual purchase price per share to be paid by Tumim for those
shares, the actual gross proceeds to be raised in connection with those sales, and whether or not we will need to register additional
shares for resale by Tumim under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The extent to which we rely on Tumim as a source of funding will
depend on a number of factors, including the prevailing market price of our Common Stock and the extent to which we are able to secure
working capital from other sources. If obtaining sufficient funding from Tumim were to prove unavailable or prohibitively dilutive, we
may need to secure another source of funding in order to satisfy our working capital needs. Even if we were to sell to Tumim all of the
shares of our Common Stock available for sale to Tumim under the Purchase Agreement, we will still need additional capital to fully implement
our business plan. Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when
we require it, the consequences would be a material adverse effect on our business, operating results, financial condition and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B><I>Future sales and issuances of our Common Stock or other
securities might result in significant dilution and could cause the price of our Common Stock to decline. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">To raise capital, we may sell our Common Stock, convertible securities
or other equity securities in one or more transactions other than those contemplated by the Purchase Agreement, at prices and in a manner
we determine from time to time. We may sell shares or other securities in any other offering at a price per share that is less than the
price per share paid by Tumim, and Tumim or investors purchasing shares or other securities in the future could have rights superior to
existing stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">The price per share at which we sell additional shares of our Common Stock, or securities convertible or exchangeable
into our Common Stock, in future transactions may be higher or lower than the price per share paid by Tumim. Any sales of additional shares
will dilute our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Sales of a substantial number of shares of our Common Stock in the
public market or the perception that these sales might occur could depress the market price of our Common Stock and could impair our ability
to raise capital through the sale of additional equity securities. We are unable to predict the effect that sales may have on the prevailing
market price of our Common Stock. In addition, the sale of substantial amounts of our Common Stock could adversely impact its price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B><I>Management will have broad discretion as to the use of the
proceeds from our sale of Common Stock to Tumim under the Purchase Agreement, and uses may not improve our financial condition or market
value. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Because we have not designated the amount of net proceeds from our
sale to Tumim of shares of our Common Stock to be used for any particular purpose, our management will have broad discretion as to the
application of such net proceeds and could use them for purposes other than those contemplated hereby. Our management may use the net
proceeds for corporate purposes that may not improve our financial condition or advance our business objectives.</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="THETUMIMTRANSACTION" TITLE="THE TUMIM TRANSACTION"></A><B>THE TUMIM TRANSACTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">On December&nbsp;8, 2021, we entered into the Purchase Agreement
with Tumim, pursuant to which Tumim has committed to purchase up to $125.0&nbsp;million of our Common Stock, at our direction from time
to time over the term of the Purchase Agreement, subject to certain terms, conditions and limitations in the Purchase Agreement. We also
entered into the Registration Rights Agreement with Tumim, pursuant to which we agreed to file with the SEC the registration statement
that includes this prospectus to register for resale under the Securities Act, the shares of our Common Stock that have been and may be
issued to Tumim under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Under the terms and subject to the conditions of the Purchase Agreement,
we have the right, but not the obligation, to sell to Tumim, and Tumim is obligated to purchase, up to $125.0&nbsp;million of our Common
Stock. Such sales of Common Stock by us, if any, will be subject to certain limitations, and may occur from time-to-time in our sole discretion,
over the period commencing once certain customary conditions are satisfied, including the filing and securing effectiveness of this resale
registration statement with the SEC with respect to the shares to be sold to Tumim under the Purchase Agreement (the &#8220;Commencement,&#8221;
and the date of the Commencement, the &#8220;Commencement Date&#8221;), and ending on the first day of the month following the 36-month
anniversary of the closing date of the Purchase Agreement (the &#8220;Termination Date&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim has no right to require the Company to sell any shares of
Common Stock to Tumim, but Tumim is obligated to make purchases as we direct, subject to certain conditions. Shares will be issued from
us to Tumim at a 3.85% discount to the one-day forward volume-weighted average price from the date a purchase notice is issued, plus an
additional fee of 2% payable to the placement agent (to a cumulative maximum of $2 million) with respect to the issuance and sale of the
shares pursuant to the Purchase Agreement. There are no upper limits on the price per share that Tumim must pay for shares of the Common
Stock. Actual sales of shares of Common Stock to Tumim will depend on a variety of factors to be determined by us from time-to-time, including,
among other things, market conditions, the trading price of our Common Stock, and determinations by us as to the appropriate sources of
funding for us and our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We do not know what the purchase price for our Common Stock will
be and therefore cannot be certain as to the number of shares we might issue to Tumim under the Purchase Agreement. Although the Purchase
Agreement provides that we may sell up to $125.0&nbsp;million of our Common Stock to Tumim, only 30,865,419 shares of our Common Stock
are being registered under the Securities Act for resale by Tumim under this prospectus, which represent the (i) 302,634 Commitment Shares
that we issued to Tumim on December&nbsp;8, 2021 as consideration of its irrevocable commitment to purchase shares of our Common Stock
under the Purchase Agreement and (ii)&nbsp;up to 30,562,785 shares of Common stock that may be issued to Tumim from and after the Commencement
Date, if and when we elect to sell shares which have been or may be issued to Tumim in the future under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If all of the 30,865,419 shares offered by Tumim for resale under
this prospectus were issued and outstanding as of the date hereof, such shares would represent approximately 16.44% of the total number
of shares of our Common Stock outstanding as of April 29, 2022. The number of shares ultimately offered for resale by Tumim is dependent
upon the number of shares we may elect to sell to Tumim under the Purchase Agreement from and after the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Under the applicable Nasdaq rules, we may not issue to Tumim under
the Purchase Agreement more than 30,865,419 shares of its Common Stock, which number of shares is equal to 19.99% of the shares of the
Company&#8217;s Common Stock outstanding (the &#8220;Exchange Cap&#8221;) as of the date of the Purchase Agreement, unless (i)&nbsp;we
obtains stockholder approval to issue shares of its Common Stock in excess of the Exchange Cap in accordance with applicable Nasdaq rules,
or (ii)&nbsp;the average purchase price per share paid by Tumim for all shares of the our Common Stock, if any, that we elect to sell
to Tumim under the Purchase Agreement equals or exceeds the lower of (a)&nbsp;the Nasdaq official closing price for our Common Stock immediately
preceding the execution of the Purchase Agreement, and (b)&nbsp;the arithmetic average of the five Nasdaq official closing prices for
the Common Stock during the 5-trading day period immediately preceding the execution of the Purchase Agreement, as adjusted so that the
Exchange Cap will not apply to issuances of Common Stock under the Purchase Agreement under applicable Nasdaq rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Moreover, we may not issue or sell any shares of our Common Stock
to Tumim under the Purchase Agreement which, when aggregated with all other shares of our Common Stock then beneficially owned by Tumim
and its affiliates (as calculated pursuant to Section&nbsp;13(d) of the Securities Exchange Act of 1934, as amended, and Rule 13d-3 promulgated
thereunder), would result in Tumim beneficially owning more than 9.99% of the outstanding shares of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The net proceeds under the Purchase Agreement to us will depend
on the frequency and prices at which we sell shares of our stock to Tumim. We expect that any proceeds received by us from such sales
to Tumim will be used for working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">As consideration for Tumim&#8217;s irrevocable commitment to purchase
shares of our Common Stock upon the terms of and subject to satisfaction of the conditions set forth in the Purchase Agreement, upon execution
of the Purchase Agreement, we issued 302,634 Commitment Shares to Tumim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Purchase of Shares Under the Purchase Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Upon the Commencement and subject to the conditions set forth in
the Purchase Agreement, we have the right, but not the obligation, from time to time at our sole discretion over the approximately 36-month
period commencing on the closing date of the Purchase Agreement, to direct Tumim to purchase amounts of our Common Stock under the Purchase
Agreement, that we specify in purchase notices that we deliver to Tumim under the Purchase Agreement on any trading day. The maximum number
of shares that may be purchased pursuant to a purchase is equal to a number of shares of our Common Stock equal to the lesser of (the
&#8220;Purchase Maximum Amount&#8221;):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the quotient obtained by dividing (A) $20,000,000 by (B)&nbsp;the last closing trade price of our Common Stock on Nasdaq on the trading
day immediately preceding the applicable day Tumim is deemed to receive a valid purchase notice for such purchase, and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the product obtained by multiplying (A)&nbsp;the daily trading volume in the Common Stock on Nasdaq on the trading day immediately
preceding the applicable day Tumim is deemed to receive a valid purchase notice for such purchase and (B) 0.15.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim is obligated to accept each purchase notice prepared and timely
delivered on or prior to 8:30 am, New York City time, on the trading day of the purchase notice for such purchase (a &#8220;Purchase Exercise
Date&#8221;) by us in accordance with the terms of and subject to the satisfaction of the conditions contained in the Purchase Agreement;
provided that, Tumim is not obligated to purchase any shares of our Common Stock set forth in a valid purchase notice in excess of the
Purchase Maximum Amount. We may deliver a purchase notice on a Purchase Exercise Date, provided that (i)&nbsp;we may not deliver more
than one purchase notices to Tumim on any single trading day and (ii)&nbsp;all shares subject to all prior purchase notices for purchases
that have been properly delivered by the us to Tumim have been received by Tumim or its broker-dealer as DWAC Shares (as defined in the
Purchase Agreement), prior to our delivery of such purchase notice to Tumim on such Purchase Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Conditions to Commencement and Delivery of Purchase Notices</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Our ability to deliver purchase notices to Tumim under the Purchase
Agreement arises upon the occurrence of satisfying of applicable conditions specified in the Purchase Agreement, all of which are entirely
outside of Tumim&#8217;s control, including, among other things, the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the accuracy in all material respects of our representations and warranties included in the Purchase Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>us having performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the
Purchase Agreement to be performed, satisfied or complied with by us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the effectiveness of this registration statement that includes this prospectus;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the SEC shall not have issued any stop order suspending the effectiveness, prohibiting or suspending the use of the registration statement
that includes this prospectus;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>there shall not have occurred any event and there shall not exist any condition or state of facts, which makes any statement of a
material fact made in the registration statement that includes this prospectus untrue or which requires the making of any additions to
or changes to the statements contained therein in order to state a material fact required by the Securities Act to be stated therein or
necessary in order to make the statements then made therein, in light of the circumstances under which they were made not misleading;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>this prospectus, in final form, shall have been filed with the SEC under the Securities Act, and all reports, schedules, registrations,
forms, statements, information and other documents required to have been filed by the Company with the SEC pursuant to the reporting requirements
of the Exchange Act, shall have been filed with the SEC;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>trading in our Common Stock shall not have been suspended by the SEC, Nasdaq or the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;),
we shall not have received any final and non-appealable notice that the listing or quotation of the Common Stock on Nasdaq shall be terminated
on a date certain (unless, prior to such date, the Common Stock is listed or quoted on the Nasdaq Global Market, the Nasdaq Capital Market,
the New York Stock Exchange or the NYSE American (or any nationally recognized successor to any of the foregoing), or each, an &#8220;Eligible
Market&#8221;), and there shall be no suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic
trading or book-entry services by DTC with respect to the Common Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>we shall have complied with all applicable federal, state and local governmental laws, rules, regulations and ordinances in connection
with the execution, delivery and performance of the Purchase Agreement and the Registration Rights Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the absence of any statute, regulation, order, decree, writ, ruling or injunction by any court or governmental authority of competent
jurisdiction which prohibits the consummation of or that would materially modify or delay any of the transactions contemplated by the
Purchase Agreement or the Registration Rights Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the absence of any action, suit or proceeding before any arbitrator or any court or governmental authority seeking to restrain, prevent
or change the transactions contemplated by the Purchase Agreement or the Registration Rights Agreement, or seeking material damages in
connection with such transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>all of the shares of our Common Stock that may be issued pursuant to the Purchase Agreement shall have been approved for listing or
quotation on the Nasdaq Capital Market (or if the Common Stock is not then listed on the Nasdaq Capital Market, on any Eligible Market);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>no condition, occurrence, state of facts or event constituting a material adverse effect shall have occurred and be continuing;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by or against us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>Tumim has received the Commitment Shares as DWAC Shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the delivery to the Company&#8217;s transfer agent of instructions and a notice of effectiveness relating to this registration statement
directing the Company&#8217;s transfer agent to issue to Tumim all the Commitment Shares and Purchase Shares as DWAC Shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the Company having reserved 30,562,785 shares of our Common Stock for the purpose of issuing Purchase Shares; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the receipt by Tumim of the opinions, bring-down opinions and negative assurances from outside counsel to us in the forms mutually
agreed to by us and Tumim prior to the date of the Purchase Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Our ability to deliver purchase notices to Tumim under the Purchase
Agreement is subject to the satisfaction of certain conditions at time of each delivery of a purchase notice, all of which are entirely
outside of Tumim&#8217;s control, including, among other things, the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the accuracy in all material respects of our representations and warranties included in the Purchase Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>us having performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the
Purchase Agreement to be performed, satisfied or complied with by us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>we shall have complied with all applicable federal, state and local governmental laws, rules, regulations and ordinances in connection
with the execution, delivery and performance of the Purchase Agreement and the Registration Rights Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the absence of any statute, regulation, order, decree, writ, ruling or injunction by any court or governmental authority of competent
jurisdiction which prohibits the consummation of or that would materially modify or delay any of the transactions contemplated by the
Purchase Agreement or the Registration Rights Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the absence of any action, suit or proceeding before any arbitrator or any court or governmental authority seeking to restrain, prevent
or change the transactions contemplated by the Purchase Agreement or the Registration Rights Agreement, or seeking material damages in
connection with such transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>all of the shares of our Common Stock that may be issued pursuant to the Purchase Agreement shall have been approved for listing or
quotation on the Nasdaq Capital Market (or if the Common Stock is not then listed on the Nasdaq Capital Market, on any Eligible Market);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>no condition, occurrence, state of facts or event constituting a material adverse effect shall have occurred and be continuing;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by or against us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the effectiveness of this registration statement that includes this prospectus (and any one or more additional registration statements
filed with the SEC that include shares of our Common Stock that may be issued and sold by us to Tumim under the Purchase Agreement);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the delivery to the Company&#8217;s transfer agent of instructions and a notice of effectiveness relating to any other additional
registration statement filed with the SEC that includes shares of our Common Stock that may be issued and sold by us to Tumim under the
Purchase Agreement directing the Company&#8217;s transfer agent to issue to Tumim all the Purchase Shares as DWAC Shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the SEC shall not have issued any stop order suspending the effectiveness, prohibiting or suspending the use of the registration statement
that includes this prospectus (or any one or more additional registration statements filed with the SEC that include shares of our Common
Stock that may be issued and sold by us to Tumim under the Purchase Agreement);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>there shall not have occurred any event and there shall not exist any condition or state of facts, which makes any statement of a
material fact made in the registration statement that includes this prospectus (or in any one or more additional registration statements
filed with the SEC that include shares of our Common Stock that may be issued and sold by us to Tumim under the Purchase Agreement) untrue
or which requires the making of any additions to or changes to the statements contained therein in order to state a material fact required
by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of this prospectus
or the prospectus included in any one or more additional registration statements filed with the SEC under the Registration Rights Agreement,
in light of the circumstances under which they were made) not misleading;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>this prospectus (or any one or more additional registration statements filed with the SEC that include shares of our Common Stock
that may be issued and sold by us to Tumim under the Purchase Agreement), in final form, shall have been filed with the SEC under the
Securities Act, and all reports, schedules, registrations, forms, statements, information and other documents required to have been filed
by the Company with the SEC pursuant to the reporting requirements of the Exchange Act, shall have been filed with the SEC;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>trading in our Common Stock shall not have been suspended by the SEC, Nasdaq or FINRA, we shall not have received any final and non-appealable
notice that the listing or quotation of the Common Stock on Nasdaq shall be terminated on a date certain (unless, prior to such date,
the Common Stock is listed or quoted on the Nasdaq Global Market, the Nasdaq Capital Market, the New York Stock Exchange or the NYSE American
(or any nationally recognized successor to any of the foregoing), or each, an Eligible Market), and there shall be no suspension of, or
restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the
Common Stock;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the issuance and sale of the Purchase Shares subject to a Purchase notice shall not exceed the Purchase Maximum Amount or cause the
Total Commitment, Beneficial Ownership Limitation (as defined in the Purchase Agreement) or Exchange Cap to be exceeded;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the Purchase Shares shall have been duly authorized and all Purchase Shares issued under prior Purchase notices shall have been delivered
as DWAC Shares; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the receipt by Tumim of the opinions, bring-down opinions and negative assurances from outside counsel to us in the forms mutually
agreed to by us and Tumim prior to the date of the Purchase Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>No Short-Selling or Hedging by Tumim </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Tumim has covenanted not to cause or engage in any manner whatsoever,
any direct or indirect short selling or hedging of our shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Prohibition on Variable Rate Transactions </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">From and after the date of the Purchase Agreement until the termination
of the Purchase Agreement, subject to exceptions provided in the Purchase Agreement, we are prohibited from effecting or entering into
an agreement to effect any issuance of Common Stock or Common Stock Equivalents (or a combination of units thereof), as such terms are
defined in the Purchase Agreement, involving a Variable Rate Transaction (as defined in the Purchase Agreement), which includes selling
convertible equity or debt securities at a future determined price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Termination of the Purchase Agreement </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Unless earlier terminated as provided in the Purchase Agreement,
the Purchase Agreement will terminate automatically on the earliest to occur of:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the first day of the month next following the 36-month anniversary of the date of the Purchase Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the date on which Tumim shall have purchased shares of our Common Stock under the Purchase Agreement for an aggregate gross purchase
price equal to its $125.0&nbsp;million total commitment under the Purchase Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the date on which the Common Stock shall have failed to be listed or quoted on the Nasdaq Capital Market or any other Eligible Market;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the date on which we commence a voluntary bankruptcy case or any third party commences a bankruptcy proceeding against us which is
not discharged within 30 trading days, a custodian is appointed for us in a bankruptcy proceeding for all or substantially all of its
property, or we make a general assignment for the benefit of its creditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We have the right to terminate the Purchase Agreement at any time
after the Commencement Date, at no cost or penalty, upon one trading day&#8217;s prior written notice to Tumim. We and Tumim may also
terminate the Purchase Agreement at any time by mutual written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Tumim also has the right to terminate the Purchase Agreement upon
1 trading days&#8217; prior written notice to us, but only upon the occurrence of certain events, including:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the occurrence of a Material Adverse Effect (as defined in the Purchase Agreement);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>the occurrence of a Fundamental Transaction (as defined in the Purchase Agreement) involving us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our failure to file with the SEC the registration statement that includes this prospectus or any additional registration statement
we are required to file with the SEC pursuant to the Registration Rights Agreement, within the time periods set forth in the Registration
Rights Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>while the registration statement that includes this prospectus or any additional registration statement or any post-effective amendments
thereto are required to be maintained effective pursuant to the Registration Rights Agreement, the effectiveness of such registration
statements or post-effective amendments lapse for any reason (including the issuance of a stop order by the SEC), or this prospectus or
the prospectus included in any additional registration statement we file with the SEC pursuant to the Registration Rights Agreement otherwise
becomes unavailable to Tumim for the resale of all of the shares of Common Stock included therein, and such lapse or unavailability continues
for a period of 30 consecutive trading days or for more than an aggregate of 120 trading days in any 365-day period, other than due to
acts of Tumim; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>trading in the Common Stock on the Nasdaq Capital Market (or if the common stock is then listed on an Eligible Market, trading in
the Common Stock on such Eligible Market) has been suspended for a period of three consecutive trading days; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>we are in material breach or default of the Purchase Agreement, and, if such breach or default is capable of being cured, such breach
or default is not cured within 10 trading days after notice of such breach or default is delivered to us.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">No termination of the Purchase Agreement by us or by Tumim will
become effective prior to the first trading day immediately following the applicable settlement date related to any pending purchase notice
that has not been fully settled in accordance with the terms and conditions of the Purchase Agreement, and will not affect any of our
respective rights and obligations under the Purchase Agreement with respect to any pending purchase notice, and both we and Tumim have
agreed to complete our respective obligations with respect to any such pending purchase notice under the Purchase Agreement. Furthermore,
no termination of the Purchase Agreement will affect the Registration Rights Agreement, which will survive any termination of the Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Effect of Performance of the Purchase Agreement on our Stockholders
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">All shares of our Common Stock that have been or may be issued or
sold by us to Tumim under the Purchase Agreement that are being registered under the Securities Act for resale by Tumim in this offering
are expected to be freely tradable. The shares of our Common Stock being registered for resale in this offering (excluding the 302,634
Commitment Shares we already issued to Tumim) may be issued and sold by us to Tumim from time to time at our discretion over a period
of up to approximately 36 months commencing on the date of execution of the Purchase Agreement, provided that the conditions precedent
to Commencement have occurred. The resale by Tumim of a significant amount of shares registered for resale in this offering at any given
time, or the perception that these sales may occur, could cause the market price of our Common Stock to decline and to be highly volatile.
Sales of our Common Stock, if any, to Tumim under the Purchase Agreement will depend upon market conditions and other factors to be determined
by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">We may ultimately decide to sell to Tumim all, some or none of the shares of our Common Stock that may be available for us to sell
to Tumim pursuant to the Purchase Agreement. If and when we do sell shares to Tumim, after Tumim has acquired the shares, Tumim may resell
all, some or none of those shares at any time or from time to time in its discretion. Therefore, sales to Tumim by us under the Purchase
Agreement may result in substantial dilution to the interests of other holders of our Common Stock. In addition, if we sell a substantial
number of shares to Tumim under the Purchase Agreement, or if investors expect that we will do so, the actual sales of shares or the mere
existence of our arrangement with Tumim may make it more difficult for us to sell equity or equity-related securities in the future at
a time and at a price that we might otherwise wish to effect such sales. However, we have the right to control the timing and amount of
any additional sales of our shares to Tumim and the Purchase Agreement may be terminated by us at any time at our discretion without any
cost to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the terms of the Purchase Agreement, we have the right,
but not the obligation, to direct Tumim to purchase up to $125.0&nbsp;million of our Common Stock, subject to certain limitations. We
have registered only a portion of the shares that may be issuable under the Purchase Agreement and, therefore, we may seek to issue and
sell to Tumim under the Purchase Agreement more shares of our Common Stock than are offered under this prospectus in order to receive
the aggregate gross proceeds equal to the $125.0&nbsp;million total commitment available to us under the Purchase Agreement. If we choose
to do so, we must first register for resale under the Securities Act any such additional shares, which could cause additional substantial
dilution to our stockholders. The number of shares ultimately offered for resale under this prospectus is dependent upon the number of
shares we direct Tumim to purchase under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The following table sets forth the amount of gross proceeds we would
receive from Tumim from our sale of Common Stock to Tumim under the Purchase Agreement at varying purchase prices:</P>

<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 58%">&nbsp;</TD>
    <TD STYLE="width: 12%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 14%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 16%; padding-left: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><B>Assumed Average Purchase Price<BR>
    Per Share</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 143.9pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Number of<BR>
    Registered<BR>
    Purchase<BR>
    Shares&nbsp;to&nbsp;be<BR>
    Issued&nbsp;if&nbsp;Full<BR>
    Purchase(1)</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 10pt 0 0; text-align: center"><B>Percentage&nbsp;of<BR>
    Outstanding<BR>
    Shares<BR>
    After&nbsp;Giving<BR>
    Effect&nbsp;to&nbsp;the<BR>
    Issuance&nbsp;to<BR>
    Tumim(2)</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 10pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Gross Proceeds<BR>
    from the<BR>
    Sale&nbsp;of&nbsp;Shares&nbsp;to<BR>
    Tumim&nbsp;Under&nbsp;the<BR>
    Purchase<BR>
    Agreement</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">$3.00</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">&#9;30,562,785&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 15pt"><FONT STYLE="font-size: 10pt">&#9;16.28&#9;%</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 4pt"><FONT STYLE="font-size: 10pt">$&nbsp;&nbsp;&#9;91,688,355&#9;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">$4.00</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">&#9;30,562,785&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 15pt"><FONT STYLE="font-size: 10pt">&#9;16.28&#9;%</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 4pt"><FONT STYLE="font-size: 10pt">$&#9;122,251,140&#9;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">$5.11(3)</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">&#9;24,461,839&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 15pt"><FONT STYLE="font-size: 10pt">&#9;13.47&#9;%</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 4pt"><FONT STYLE="font-size: 10pt">$&#9;124,999,997</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">$6.00</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">&#9;20,833,333&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 15pt"><FONT STYLE="font-size: 10pt">&#9;11.70&#9;%</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 4pt"><FONT STYLE="font-size: 10pt">$&#9;124,999,998&#9;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">$7.00</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 5pt"><FONT STYLE="font-size: 10pt">&#9;17,857,142&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 15pt"><FONT STYLE="font-size: 10pt">&#9;10.20&#9;%</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; padding-left: 4pt"><FONT STYLE="font-size: 10pt">$&#9;124,999,994&#9;</FONT></TD></TR>





  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 6.6in 1pt 0in"></DIV>

<DIV STYLE="margin: 1pt 6.6in 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(1)</TD><TD>Although the Purchase Agreement provides that we may sell up to $125.0&nbsp;million of our Common Stock to Tumim, we are only registering
30,865,419 shares under this prospectus which represents: (i) 302,634 Commitment Shares that we already issued to Tumim as a commitment
fee for making the irrevocable commitment under the Purchase Agreement; and (ii)&nbsp;an additional 30,562,785 shares which may be issued
to Tumim in the future under the Purchase Agreement, if and when we sell shares to Tumim under the Purchase Agreement, and which may or
may not cover all the shares we ultimately sell to Tumim under the Purchase Agreement, depending on the purchase price per share. As a
result, we have included in this column only those shares that we are registering in this offering. If we seek to issue under the Purchase
Agreement and the transactions contemplated thereby, shares of our Common Stock in excess of 30,865,419 shares, or 19.99% of the total
Common Stock outstanding, we may be required to seek stockholder approval in order to be in compliance with the Nasdaq listing rules.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(2)</TD><TD>The denominator is based on 157,151,687 shares outstanding as April 29, 2022, which includes the 302,634 Commitment Shares issued
to Tumim upon execution of the Purchase Agreement and adjusted to include the number of shares set forth in the adjacent column which
we would have sold to Tumim, assuming the purchase price in the first column. The numerator is based on the number of shares issuable
under the Purchase Agreement at the corresponding assumed purchase price set forth in the first column.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(3)</TD><TD>The closing sale price of our Common Stock on April 29, 2022.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="USEOFPROCEEDS" TITLE="USE OF PROCEEDS"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus relates to shares of our Common Stock that may be
offered and sold from time to time by Tumim. All of the Common Stock offered by Tumim pursuant to this prospectus will be sold by Tumim
for its own account. We will not receive any of the proceeds from these sales. We may receive up to $125.0&nbsp;million aggregate gross
proceeds under the Purchase Agreement from any sales we make to Tumim pursuant to the Purchase Agreement. We estimate that the net proceeds
to us from the sale of our Common Stock to Tumim pursuant to the Purchase Agreement will be up to $124,865,379.14 over an approximately
36-month period commencing on the Commencement Date, provided that the conditions precedent to the Commencement have occurred, and assuming
that we sell the full amount of our Common Stock that we have the right, but not the obligation, to sell to Tumim under the Purchase Agreement,
and after estimated fees and expenses. See &#8220;Plan of Distribution&#8221; elsewhere in this prospectus for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We expect to use any proceeds that we receive under the Purchase
Agreement for working capital and general corporate purposes. As of the date of this prospectus, we cannot specify with certainty all
of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. Accordingly, we will
retain broad discretion over the use of these proceeds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="SELLINGSTOCKHOLDERS" TITLE="SELLING STOCKHOLDERS"></A>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This prospectus relates to the possible resale from time to time
by Tumim of any or all of the shares of Common Stock that may be issued by us to Tumim under the Purchase Agreement. For additional information
regarding the issuance to Tumim of Common Stock covered by this prospectus, see the section entitled &#8220;The Tumim Transaction&#8221;
above. We are registering the shares of Common Stock pursuant to the provisions of the Registration Rights Agreement we entered into with
Tumim on December&nbsp;8, 2021 in order to permit Tumim to offer the shares for resale from time to time. Except for the transactions
contemplated by the Purchase Agreement and the Registration Rights Agreement, Tumim has not had any material relationship with us within
the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">The table below presents information regarding the Selling Stockholder
and the shares of Common Stock that it may offer from time to time under this prospectus. This table is prepared based on information
supplied to us by the Selling Stockholder, and reflects holdings as of April 29, 2022. The number of shares in the column &#8220;Maximum
Number of Shares of Common Stock to be Offered Pursuant to this Prospectus&#8221; represents all of the shares of Common Stock that the
Selling Stockholder may offer for resale under this prospectus. The Selling Stockholder may sell some, all or none of its shares in this
offering. We do not know how long the Selling Stockholder will hold the shares before selling them, and we are not aware of any existing
arrangements between the Selling Stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution
of the shares of our Common Stock being offered for resale by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Beneficial ownership is determined in accordance with Rule 13d-3(d)
promulgated by the SEC under the Exchange Act, and includes shares of Common Stock with respect to which the Selling Stockholder has sole
or shared voting and investment power. The percentage of shares of Common Stock beneficially owned by the Selling Stockholder prior to
the offering shown in the table below is based on an aggregate of 157,151,687 shares of our Common Stock outstanding on April 29, 2022.
Because the purchase price of the shares of Common Stock issuable under the Purchase Agreement is determined on the applicable Purchase
Date with respect to a purchase, the number of shares that may actually be sold by us under the Purchase Agreement may be fewer than the
number of shares being offered by this prospectus. The fourth column assumes the sale of all of the shares offered by the Selling Stockholder
pursuant to this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 7%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 17%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 10%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 7%; padding-left: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt"><B>Names and Addresses</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Number of Shares<BR>
    of Common Stock<BR>
    Owned Prior to<BR>
    Offering</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD ROWSPAN="2" STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Maximum&nbsp;Number&nbsp;of<BR>
    Shares&nbsp;of&nbsp;Common&nbsp;Stock<BR>
    to&nbsp;be&nbsp;Offered&nbsp;Pursuant&nbsp;to<BR>
    this Prospectus</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD COLSPAN="2" STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Number of Shares<BR>
    of Common Stock<BR>
    Owned After<BR>
    Offering</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 12pt/1pt Times New Roman, Times, Serif; padding-top: 1pt; padding-left: 0.1in; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Number&nbsp;(1)</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Percent</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Number&nbsp;(2)</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Percent</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 12pt; text-indent: -12pt"><FONT STYLE="font-size: 10pt">Tumim Stone Capital LLC&nbsp;(3)&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 4pt; text-align: right"><FONT STYLE="font-size: 10pt">&#9;302,634&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">&#9;*&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 24pt; text-align: right"><FONT STYLE="font-size: 10pt">&#9;30,865,419&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25in"><FONT STYLE="font-size: 10pt">&#9;0&#9;</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; font: 12pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">&#9;*&#9;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 4pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 6.6in 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 0.75pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">*</TD><TD>less than 1%</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(1)</TD><TD>Consists of 302,634 shares of Common Stock we issued to Tumim on December&nbsp;8, 2021 as Commitment Shares in consideration for entering
into the Purchase Agreement. In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially
owned prior to the offering all of the shares that Tumim may be required to purchase under the Purchase Agreement because the issuance
of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement, the satisfaction of which
are entirely outside of Tumim&#8217;s control, including with respect to the Purchase Agreement the registration statement that includes
this prospectus becoming and remaining effective. Furthermore, purchases of shares of our Common Stock are subject to certain agreed upon
maximum amount limitations set forth in the Purchase Agreement. The Purchase Agreement prohibits us from issuing and selling any shares
of our Common Stock to Tumim to the extent such shares, when aggregated with all other shares of our Common Stock then beneficially owned
by Tumim and its affiliates, would cause Tumim&#8217;s beneficial ownership of our Common Stock to exceed the 9.99% Beneficial Ownership
Limitation. The Purchase Agreement also prohibit us from issuing or selling shares of our Common Stock under the Purchase Agreement and
the transactions contemplated thereby, in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so, or unless
the average price of all sales of Common Stock under the Purchase Agreement (including the commitment shares issued thereunder) are made
at a price equal to or greater than $4.90 per share, such that the Exchange Cap limitation would not apply under the Nasdaq listing rules.
Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under the Nasdaq listing rules) may be amended
or waived under the Purchase Agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(2)</TD><TD>Assumes the sale of all shares being offered pursuant to this prospectus. Depending on the price per share at which we sell our Common
Stock to Tumim pursuant to the Purchase Agreement, we may need to sell to Tumim under the Purchase Agreement more shares of our Common
Stock than are offered under this prospectus in order to receive aggregate gross proceeds equal to the $125.0&nbsp;million Total Commitment
available to us under the Purchase Agreement. If we choose to do so, we must first register for resale under the Securities Act such additional
shares. The number of shares ultimately offered for resale by Tumim is dependent upon the number of shares we sell to Tumim under the
Purchase Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(3)</TD><TD>The business address of Tumim Stone Capital LLC is 140 Broadway, 38th Floor, New York, NY 10005. Tumim Stone Capital LLC&#8217;s principal
business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, which
is the sole member of Tumim Stone Capital LLC, and has sole voting control and investment discretion over securities beneficially owned
directly by Tumim Stone Capital LLC and indirectly by 3i Management, LLC and 3i, LP. 3i Management, LLC is also the manager of Tumim Stone
Capital LLC. We have been advised that none of Mr.&nbsp;Tarlow, 3i Management, LLC, 3i, LP or Tumim Stone Capital LLC is a member of FINRA,
or an independent broker-dealer, or an affiliate or associated person of a FINRA member or independent broker-dealer. The foregoing should
not be construed in and of itself as an admission by Mr.&nbsp;Tarlow as to beneficial ownership of the securities beneficially owned directly
by Tumim Stone Capital LLC and indirectly by 3i Management, LLC and 3i, LP.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="DESCRIPTIONOFOURSECURITIES" TITLE="DESCRIPTION OF OUR SECURITIES"></A>DESCRIPTION OF OUR SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The following description of our securities is a summary and does
not purport to be complete. The description is subject to and qualified in its entirety by reference to (i)&nbsp;our Amended Charter,
(ii)&nbsp;our Amended Bylaws, (iii)&nbsp;the Warrant Agreement, dated as of November&nbsp;12, 2020, between the Company and Continental
Stock Transfer&nbsp;&amp; Trust Company (the &#8220;Warrant Agreement&#8221;), (iv) the Registration Rights Agreement, dated as of December&nbsp;8,
2021, between the Company and Tumim Stone Capital LLC (the &#8220;Registration Rights Agreement&#8221;),  (v)&nbsp;the Form of Indemnification
Agreement, each of which is incorporated by reference as exhibits to this prospectus, and (vi) the Registration Rights Agreement, dated as of September 15,
2022, between the Company and 3i, LP (the &ldquo;Note Registration Rights Agreement&rdquo;), each of which is incorporated by reference as an exhibit or incorporated by
reference by filings incorporated into this Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>General </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Our purpose is to engage in any lawful act or activity for which
corporations may be organized under the Delaware General Corporation Law (&#8220;DGCL&#8221;). Our authorized capital stock consists of
300,000,000 shares of Common Stock and (b) 1,000,000 shares of preferred stock, par value $0.0001 per share. As of the date of this prospectus,
no shares of preferred stock are issued or outstanding. Unless our Board determines otherwise, we will issue all shares of our capital
stock in uncertificated form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Description of Common Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><I>Voting Rights.</I> Each holder of Common Stock is entitled to
one (1)&nbsp;vote in person or by proxy for each share of the Common Stock held of record by such holder. The holders of shares of the
Common Stock do not have cumulative voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Dividend Rights.</I> Subject to any other provisions of the Amended
Charter, each holder of Common Stock is entitled to receive such dividends and other distributions in cash, stock or property of the Company
when, as and if declared thereon by our Board from time to time out of assets or funds of the Company legally available therefor and shall
share equally on a per share basis in such dividends and distributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Liquidation Rights.</I> In the event of any voluntary or involuntary
liquidation, dissolution or winding up of the Company, subject to applicable law, the rights, if any, of the holders of any outstanding
series of the preferred stock, after payment or provision for payment of the debts and other liabilities of the Company, the holders of
the shares of Common Stock are entitled to receive all the remaining assets of the Company available for distribution to its stockholders,
ratably in proportion to the number of shares of Common Stock held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Other Matters.</I> The rights, preferences and privileges of
the holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of
our preferred stock, including any series of preferred stock which we may designate in the future. There are no redemption or sinking
fund provisions applicable to the Common Stock. All outstanding shares of Common Stock are fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Listing. </I>The Common Stock is listed for trading on Nasdaq
under the symbol &#8220;LIDR&#8221;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Transfer Agent. </I>Continental Stock Transfer&nbsp;&amp; Trust
Company acts as the transfer agent of the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Description of Preferred Stock </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Under the terms of the Amended Charter, our Board has the authority,
without stockholder approval, to issue shares of preferred stock from time to time on terms it may determine, to divide shares of preferred
stock into one or more class or series and to fix for each such class or series the designations, preferences, privileges, and restrictions
of preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption, liquidation preference, and the
number of shares constituting any series or the designation of any series to the fullest extent permitted by the DGCL. The issuance of
preferred stock could have the effect of decreasing the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">trading price of the Common Stock, restricting dividends on our capital
stock, diluting the voting power of the Common Stock, impairing the liquidation rights of our capital stock, or delaying or preventing
a change in control of the Company. Although we do not currently intend to issue any shares of preferred stock, we cannot assure you that
we will not do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Description of Warrants </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><I>Form. </I>The Warrants were issued under the Warrant Agreement.
The material terms and provisions of the Warrants are summarized below, but the following description is subject to, and qualified in
its entirety by, the Warrant Agreement and the form of Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Exercisability</I>. The Warrants are currently exercisable and
may be exercised at any time up to five (5)&nbsp;years from August&nbsp;16, 2021 or earlier upon redemption or liquidation, as applicable,
at the option of each holder by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares
of Common Stock purchased upon such exercise (except in the case of a cashless exercise as discussed below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><I>Cashless Exercise</I>. If the Common Stock is at the time of any
exercise of a Warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221;
under Section&nbsp;18(b)(1) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), the Company may, at its option,
require holders of the Warrants who exercise such Warrants to exercise on a &#8220;cashless basis&#8221; in accordance with Section&nbsp;3(a)(9)
of the Securities Act as described in the Warrant Agreement, and in the event the Company so elects, the Company is not be required to
file or maintain in effect a registration statement for the registration under the Securities Act of the Common Stock issuable upon exercise
of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Notwithstanding the foregoing, the Private Placement Warrants may
be exercised pursuant to a &#8220;cashless exercise&#8221; so long as such Private Placement Warrant is held by Sponsor or its permitted
transferees (as defined in the Warrant Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Exercise Price.</I> Each Warrant represents the right to purchase
one share Common Stock at an original exercise price of $11.50 per share, subject to adjustments as described in the Warrant Agreement,
including a stock split or similar events and payments of certain dividends to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Redemption</I>. Other than the Private Placement Warrants, the
Company may, at its option, redeem all of the outstanding Warrants at any time while they are exercisable and prior to their expiration
upon notice to the holders thereof, at the price of $0.01 per Warrant, provided that (i)&nbsp;the last sales price of the Common Stock
reported has been at least $18.00 per share (subject to adjustments as described in the Warrant Agreement), on each of twenty (20)&nbsp;trading
days within the thirty (30)&nbsp;trading day period ending on the third trading day prior to the date on which the notice of redemption
is given and (ii)&nbsp;there is an effective registration statement covering the shares of Common Stock issuable upon exercise of the
Warrants, and a current prospectus relating thereto, available throughout the redemption period, or the Company has elected to require
the exercise of the Warrants on a &#8220;cashless basis&#8221;. The Warrants may be exercised at any time after notice of redemption shall
have been given by the Company and prior to the redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Rights as a Stockholder.</I> Except as otherwise provided in
the Warrants or by virtue of such holder&#8217;s ownership of shares of our Common Stock, the holder of a Warrant does not have the rights
or privileges of a holder of our Common Stock, including any voting rights, until the holder exercises the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Listing. </I>The Warrants are listed for trading on the Nasdaq
under the symbol &#8220;LIDRW&#8221;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Warrant Agent.</I> Continental Stock Transfer&nbsp;&amp; Trust
Company acts as the warrant agent and transfer agent for the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Registration Rights </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 12pt">The Company is a party to the Registration Rights Agreement entered
in connection with a transaction pursuant to which Tumim Stone Capital LLC has committed to purchase the Company&#8217;s Common Stock.
The Registration Rights Agreement requires the Company to prepare and file a registration statement to cover the resale under the Securities
Act of registrable securities held by Tumim Stone Capital LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">The Company is also a party to the Note Registration Rights Agreement
entered in connection with a transaction pursuant to which the Company has issued to 3i, LP a senior unsecured convertible promissory note
and a warrant to purchase the Company&rsquo;s Common Stock. The Note Registration Rights Agreement requires the Company to prepare and
file a registration statement to cover the resale of the Company's Common Stock issuable upon conversion of the note and/or exercise
of the warrant. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Provisions of Our Amended Charter and Bylaws and Delaware Law
That May Have Anti-Takeover Effects </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><I>Section&nbsp;203 of the Delaware General Corporation Law </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Section&nbsp;203 of the DGCL is applicable to takeovers of certain
Delaware corporations, including us. Subject to exceptions enumerated therein, Section&nbsp;203 provides that a corporation shall not
engage in any business combination with any &#8220;interested stockholder&#8221; for a three-year period following the date that the stockholder
becomes an interested stockholder unless:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>prior to that date, the board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, though some shares may be
excluded from the calculation; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>on or subsequent to that date, the business combination is approved by the board of directors of the corporation and by the affirmative
votes of holders of at least two-thirds of the outstanding voting stock that is not owned by the interested stockholder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The term &#8220;business combination&#8221; is defined to include,
among other transactions between an interested stockholder and a corporation or any direct or indirect majority owned subsidiary thereof:
a merger or consolidation; a sale, lease, exchange, mortgage, pledge, transfer or other disposition (including as part of a dissolution)
of assets having an aggregate market value equal to 10% or more of either the aggregate market value of all assets of the corporation
on a consolidated basis or the aggregate market value of all the outstanding stock of the corporation; certain transactions that would
result in the issuance or transfer by the corporation of any of its stock to the interested stockholder; certain transactions that would
increase the interested stockholder&#8217;s proportionate share ownership of the stock of any class or series of the corporation or such
subsidiary; and any receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial
benefits provided by or through the corporation or any such subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Except as specified in Section&nbsp;203, an interested stockholder
is generally defined to include any person who, together with any affiliates or associates of that person, beneficially owns, directly
or indirectly, 15% or more of the outstanding voting stock of the corporation, or is an affiliate or associate of the corporation and
was the owner of 15% or more of the outstanding voting stock of the corporation, any time within three years immediately prior to the
relevant date. Under certain circumstances, Section&nbsp;203 makes it more difficult for an interested stockholder to effect various business
combinations with a corporation for a three-year period, although the stockholders may elect not to be governed by this section, by adopting
an amendment to the Amended Charter or the Bylaws, effective 12 months after adoption. Our Amended Charter and Bylaws do not opt out from
the restrictions imposed under Section&nbsp;203. We anticipate that the provisions of Section&nbsp;203 may encourage companies interested
in acquiring us to negotiate in advance with the board of directors because the stockholder approval requirement would be avoided if a
majority of the directors then in office excluding an interested stockholder approve either the business combination or the transaction
that resulted in the stockholder becoming an interested stockholder. These provisions may have the effect of deterring hostile takeovers
or delaying changes in control, which could depress the market price of our Common Stock and deprive stockholders of opportunities to
realize a premium on shares of Common Stock held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Amended Charter and Bylaw Provisions </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">In addition to the board of directors&#8217; ability to issue shares
of preferred stock, our Amended Charter and Amended Bylaws contain the following provisions that may have the effect of discouraging unsolicited
acquisition proposals:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws classify the board of directors into three classes with staggered three-year terms (except
for certain initial year terms);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>under our Amended Charter and Amended Bylaws, our Board may enlarge the size of the board and fill the vacancies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws provide that a stockholder may not nominate candidates for the board of directors at any annual
or special meeting unless that stockholder notifies us of its intention a specified period in advance and provides us with certain required
information;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws provide that stockholders may remove our directors only for cause;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws provide that stockholders who wish to bring business before the stockholders at our annual
meeting must provide advance notice;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws provide that, except for limited exceptions, any action required or permitted to be taken by
the stockholders must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent
of the stockholders; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>our Amended Charter and Amended Bylaws provide that special meetings of stockholders may only be called by the chairman of our Board,
our Chief Executive Officer or our Board pursuant to a resolution adopted by a majority of our Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Our Amended Charter and Amended Bylaws also provide that, unless
we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive
forum for:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any derivative action or proceeding brought on our behalf;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to us or
our stockholders;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any action asserting a claim arising pursuant to any provision of the DGCL or our Charters; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any action asserting a claim governed by the internal affairs doctrine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Our Amended Charter and Amended Bylaws further provide that any person
or entity purchasing or otherwise acquiring any interest in shares of capital stock of the company is deemed to have notice of and consented
to the foregoing provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Quorum. </I>Unless otherwise required by the DGCL or other applicable
law, the holders of a majority of the voting power of our capital stock issued and outstanding and entitled to vote thereat, present in
person or represented by proxy, will constitute a quorum at all meetings of the stockholders for the transaction of business except as
otherwise required by law or provided by the certificate of incorporation. If, however, such quorum will not be present or represented
at any meeting of the stockholders, such stockholders will have power to adjourn the meeting from time to time until a quorum shall attend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><I>Authorized but Unissued Capital Stock</I>. The DGCL does not require
stockholder approval for any issuance of authorized shares. However, the listing requirements of NASDAQ, which would apply if and so long
as the Common Stock remains listed on NASDAQ, require stockholder approval of certain issuances equal to or exceeding 20% of the then
outstanding voting power or then outstanding number of shares of the Common Stock. Additional shares that may be issued in the future
may be used for a variety of corporate purposes, including future public offerings, to raise additional capital or to facilitate acquisitions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">One of the effects of the existence of unissued and unreserved Common Stock
may be to enable our Board to issue shares to persons friendly to current management, which issuance could render more difficult or discourage
an attempt to obtain control of the Company by means of a merger, tender offer, proxy contest or otherwise and thereby protect the continuity
of management and possibly deprive stockholders of opportunities to sell their shares of the Common Stock at prices higher than prevailing
market prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Annual Stockholder Meetings. </I>Our Amended Bylaws provide that
annual stockholder meetings will be held at a date, time and place, if any, as exclusively selected by our Board. To the extent permitted
under applicable law, our Board may conduct meetings by remote communications. Our Amended Bylaws provide that stockholders seeking to
bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of
stockholders, must provide timely notice of their intent in writing. To be timely, a stockholder&#8217;s notice will need to be received
by our Secretary at our principal executive offices not later than the close of business on the 90th day nor earlier than the open of
business on the 120th day prior to the anniversary date of the immediately preceding our annual meeting of stockholders. Pursuant to Rule
14a-8 of the Exchange Act, proposals seeking inclusion in our annual proxy statement must comply with the notice periods contained in
the annual proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">Our Amended Charter specifies certain requirements as to the form and content of a stockholders&#8217; meeting.
These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations
for directors at our annual meeting of stockholders. Our Amended Bylaws also specify certain requirements as to the form and content of
a stockholder&#8217;s notice for an annual meeting. Specifically, a stockholder&#8217;s notice must include: (i)&nbsp;a brief description
of the business desired to be brought before the annual meeting, the text of the proposal or business (including the text of any resolutions
proposed for consideration and in the event such business includes a proposal to amend the bylaws, the language of the proposed amendment)
and the reasons for conducting such business at the annual meeting, (ii)&nbsp;the name and record address of such stockholder and the
name and address of the beneficial owner, if any, on whose behalf the proposal is made, (iii)&nbsp;the class or series and number of shares
of our capital stock that are owned beneficially and of record by such stockholder and by the beneficial owner, if any, on whose behalf
the proposal is made, (iv)&nbsp;a description of all arrangements or understandings between such stockholder and the beneficial owner,
if any, on whose behalf the proposal is made and any other person or persons (including their names) in connection with the proposal of
such business by such stockholder, (v)&nbsp;any material interest of such stockholder and the beneficial owner, if any, on whose behalf
the proposal is made in such business and (vi)&nbsp;a representation that such stockholder (or a qualified representative of such stockholder)
intends to appear in person or by proxy at the annual meeting to bring such business before the meeting. These notice requirements will
be deemed satisfied by a stockholder as to any proposal (other than nominations) if the stockholder has notified us of such stockholder&#8217;s
intention to present such proposal at an annual meeting in compliance with Rule 14a-8 (or any successor thereof) of the Exchange Act,
and such stockholder has complied with the requirements of such rule for inclusion of such proposal in a proxy statement prepared by us
to solicit proxies for such annual meeting. The foregoing provisions may limit our stockholders&#8217; ability to bring matters before
our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Special Meetings</I>. The Amended Charter provides that special
meetings of our stockholders may be called only by the chairman of our Board, our Chief Executive Officer or our Board pursuant to a resolution
adopted by a majority of our Board. Our stockholders will not be eligible and will have no right to call a special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Our Amended Bylaws also provide that unless otherwise restricted
by the Amended Charter or the Amended Bylaws, any action required or permitted to be taken at any meeting of our Board or of any committee
thereof may be taken without a meeting, if all members of our Board or committee thereof, as the case may be, consent thereto in writing
or by electronic transmission, and the writing or writings or electronic transmission or transmissions (or paper reproductions thereof)
are filed with the minutes of proceedings of our Board or committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Amendment. </I>The DGCL provides generally that the affirmative
vote of a majority of the outstanding stock entitled to vote on amendments to a corporation&#8217;s certificate of incorporation or bylaws
is required to approve such amendment, unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires
a greater percentage. The Amended Bylaws may be amended, altered or repealed (A)&nbsp;by the affirmative vote of a majority of our entire
Board; or (B)&nbsp;by the affirmative vote of the holders of at least a majority of the voting power of the shares entitled to vote at
an election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>Limitations on Liability and Indemnification of Officers and
Directors. </I>The DGCL authorizes corporations to limit or eliminate the personal liability of directors to corporations and their stockholders
for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. We have entered, and expect to
continue to enter, into agreements to indemnify our directors, executive officers and other employees as determined by our Board. Under
the terms of such indemnification agreements, we are required to indemnify each of our directors and officers, to the fullest extent permitted
by the laws of the state of Delaware, if the basis of the indemnitee&#8217;s involvement was by reason of the fact that the indemnitee
is or was a director or officer of the Company or any of its subsidiaries or was serving at the Company&#8217;s request in an official
capacity for another entity. We must indemnify our officers and directors against all expenses, judgments, fines, penalties and amounts
paid in settlement (if pre-approved), including all costs, expenses and obligations incurred in connection with investigating, defending,
being a witness in, participating in (including on appeal), or preparing to defend, be a witness or participate in any completed, actual,
pending or threatened action, suit, proceeding or alternative dispute resolution mechanism, whether civil, criminal, administrative, investigative
or other, arising out of the officers&#8217; or directors&#8217; role as an officer or director of the Company, or establishing or enforcing
a right to indemnification under the indemnification agreement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="PLANOFDISTRIBUTION" TITLE="PLAN OF DISTRIBUTION"></A><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">We are registering the resale of up to 30,865,419 shares of Common
Stock by Tumim. Tumim will pay all sales and brokerage commissions and similar expenses in connection with the offer and resale of the
Common Stock by Tumim pursuant to this prospectus. We will pay the expenses (except sales and brokerage commissions and similar expenses)
incurred in registering under the Securities Act the offer and resale of the shares included in this prospectus by Tumim, including legal
and accounting fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The shares of Common Stock covered by this prospectus may be offered
and sold from time to time by the Selling Stockholder. The Selling Stockholder will act independently of us in making decisions with respect
to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise,
at prices and under terms then prevailing or at prices related to the then-current market price or in negotiated transactions. The Selling
Stockholder may sell their shares of Common Stock by one or more of, or a combination of, the following methods:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>ordinary brokers&#8217; transactions;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>transactions involving cross or block trades;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>through brokers, dealers, or underwriters who may act solely as agents;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>&#8220;at the market&#8221; into an existing market for the ordinary shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected
through agents;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>in privately negotiated transactions; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36.7pt"></TD><TD STYLE="width: 18.35pt">&#8226;</TD><TD>any combination of the foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">In order to comply with the securities laws of certain states, if
applicable, the Common Stock may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the Common
Stock may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state&#8217;s registration
or qualification requirement is available and complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim is an &#8220;underwriter&#8221; within the meaning of Section&nbsp;2(a)(11)
of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim has informed us that it intends to use one or more registered
broker-dealers to effectuate all sales, if any, of our Common Stock that it has acquired and may in the future acquire from us pursuant
to the Purchase Agreement. Such sales will be made at prices and at terms then prevailing or at prices related to the then current market
price. Each such registered broker-dealer will be an underwriter within the meaning of Section&nbsp;2(a)(11) of the Securities Act. Tumim
has informed us that each such broker-dealer will receive commissions from Tumim that will not exceed customary brokerage commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Brokers, dealers, underwriters or agents participating in the distribution
of the shares of our Common Stock offered by this prospectus may receive compensation in the form of commissions, discounts, or concessions
from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by the Selling Stockholder through this prospectus.
The compensation paid to any such particular broker-dealer by any such purchasers of shares of our Common Stock sold by the Selling Stockholder
may be less than or in excess of customary commissions. Neither we nor the Selling Stockholder can presently estimate the amount of compensation
that any agent will receive from any purchasers of shares of our Common Stock sold by the Selling Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We know of no existing arrangements between the Selling Stockholder
or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the shares of our Common Stock
offered by this prospectus.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">We may from time to time file with the SEC one or more supplements to this
prospectus or amendments to the registration statement of which this prospectus forms a part to amend, supplement or update information
contained in this prospectus, including, if and when required under the Securities Act, to disclose certain information relating to a
particular sale of shares offered by this prospectus by the Selling Stockholder, including the names of any brokers, dealers, underwriters
or agents participating in the distribution of such shares by the Selling Stockholder, any compensation paid by the Selling Stockholder
to any such brokers, dealers, underwriters or agents, and any other required information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We will pay the expenses incident to the registration under the
Securities Act of the offer and resale of the shares of our Common Stock covered by this prospectus by Tumim. As consideration for its
irrevocable commitment to purchase our Common Stock under the Purchase Agreement, we have issued to Tumim 302,634 shares of our Common
Stock as Commitment Shares. We also reimbursed Tumim for the fees and disbursements of its counsel incurred in connection with the Purchase
Agreement in the amount of $50,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">We also have agreed to indemnify Tumim and certain other persons
against certain liabilities in connection with the offering of shares of our Common Stock offered hereby, including liabilities arising
under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities.
Tumim has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished
to us by Tumim specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid
in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors,
officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as
expressed in the Securities Act and is therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Reedland Capital Partners, acting through Weild &amp; Co., member
FINRA/SIPC (&#8220;Reedland&#8221;), acted as placement agent in connection with this offering. Pursuant to the terms of an engagement
agreement we entered into with Reedland, upon settlement of each purchase that we may, in our sole discretion, direct Tumim Stone to make
under the Purchase Agreement from time to time after the date of this prospectus, we have agreed to pay Reedland a cash placement fee
equal to 2% of the aggregate gross purchase price paid by Tumim for the shares of common stock purchased by Tumim in such purchase, up
to a cumulative maximum amount of $2.0&nbsp;million. We have agreed to indemnify and hold harmless Reedland against certain liabilities,
including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We estimate that the total expenses for the offering will be approximately
$134,620.86.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Tumim has agreed that during the term of the Purchase Agreement,
neither Tumim, nor any of its agents, representatives or affiliates will enter into or effect, directly or indirectly, any short sale
(as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our Common Stock or any hedging transaction, which establishes
a net short position with respect to our Common Stock. We have advised the Selling Stockholder that it is required to comply with Regulation
M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the Selling Stockholder, any affiliated purchasers,
and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any
person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation
M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that
security. All of the foregoing may affect the marketability of the securities offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This offering will terminate on the date that all shares of our
Common Stock offered by this prospectus have been sold by the Selling Stockholder.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="LEGALMATTERS" TITLE="LEGAL MATTERS"></A><B>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The validity of the shares of Common Stock offered hereby will be
passed upon for us by Shearman&nbsp;&amp; Sterling LLP, Menlo Park, California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><A NAME="EXPERTS" TITLE="EXPERTS"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">The financial statements of AEye, Inc. as of December&nbsp;31, 2021
and 2020, and for each of the two years in the period ended December&nbsp;31, 2021, incorporated by reference in this Prospectus have
been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial
statements are incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="MOREINFORMATION" TITLE="WHERE YOU CAN FIND MORE INFORMATION"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 0.5in"><FONT STYLE="background-color: white">This prospectus
is part of a registration statement on&nbsp;Form&nbsp;S-3&nbsp;that we filed with the SEC.&nbsp;</FONT>This prospectus, which constitutes
a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits
and schedules filed therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">We are required to file annual, quarterly and current
reports, proxy statements and other information with the SEC as required by the Exchange Act. You can read our SEC filings, including this prospectus,
over the Internet at the SEC&#8217;s website at <FONT STYLE="color: Blue"><U>http://www.sec.gov</U></FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Our website address is https://www.aeye.ai/. Through
our website, we make available, free of charge, the following documents as soon as reasonably practicable after they are electronically
filed with, or furnished to, the SEC, including our Annual Reports on Form 10-K; our proxy statements for our annual and special stockholder
meetings; our Quarterly Reports on Form 10-Q; our Current Reports on Form 8-K; Forms 3, 4, and 5 and Schedules 13D with respect to our
securities filed on behalf of our directors and our executive officers; and amendments to those documents. The information contained on,
or that may be accessed through, our website is not a part of, and is not incorporated into, this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">This prospectus and any applicable prospectus
supplement are part of a registration statement that we filed with the SEC, but do not contain all of the information in the registration
statement. The full registration statement may be obtained from the SEC or us, as provided below. Statements in the prospectus or any
prospectus supplement about these documents are summaries and each statement is qualified in all respects by reference to the document
to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect
a copy of the registration statement through the SEC&#8217;s website, as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><A NAME="INFORMATIONINCORPORATEDBYREF" TITLE="INFORMATION INCORPORATED BY REFERENCE"></A>INFORMATION INCORPORATED BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">The SEC rules allow us to &#8220;incorporate
by reference&#8221; information into this prospectus, which means that we can disclose important information to you by referring you to
another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and
subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in
this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this
prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies
or replaces that statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">This prospectus and any accompanying prospectus
supplement incorporate by reference the documents set forth below that have previously been filed with the SEC:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 28, 2022;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="background-color: white">our Quarterly Reports on Form&nbsp;10-Q&nbsp;for the quarterly periods ended March&nbsp;31,
2022 and June&nbsp;30, 2022, filed with the SEC on&nbsp;May 13, 2022 and&nbsp;August 15, 2022, respectively;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>our Current Reports on Form 8-K filed with the SEC on January 18, 2022, March 18, 2022, May 11, 2022, May 13, 2022, August 24, 2022
and September 16, 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">All reports and other documents we subsequently
file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act in this prospectus, prior to the termination of this offering,
including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness
of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated
by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">You may request a free copy of any documents
incorporated by reference in this prospectus by writing or telephoning us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">AEye, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">Attn: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">One Park Place, Suite 200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">Dublin, CA 94568</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">(925) 400-4366</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt; text-indent: 0.5in">Exhibits to the filings will not be sent,
however, unless those exhibits have been specifically incorporated by reference in this prospectus or any accompanying prospectus supplement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0.25in 0 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0.25in 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Part II </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>Item&nbsp;14. Other Expenses of Issuance and Distribution. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">The following table indicates the estimated expenses to be incurred
in connection with the offering described in this registration statement, other than underwriting discounts and commissions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="background-color: White; font: 12pt Times New Roman, Times, Serif; padding-left: 0.1in">&nbsp;</TD><TD STYLE="background-color: White; font-family: Times New Roman, Times, Serif; font-weight: bold">&nbsp;</TD>
    <TD STYLE="background-color: White; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="background-color: White; border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Amount</B></P> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 71%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Securities and Exchange Commission registration fee&#9;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 18%; font: 10pt Times New Roman, Times, Serif; text-align: right">14,620.86</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Accounting fees and expenses&#9;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">35,000</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Legal fees and expenses&#9;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">45,000</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Financial printing and miscellaneous expenses&#9;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">66,000</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 0.1in">&nbsp;</TD><TD STYLE="font-size: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 1pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -12pt; padding-left: 12pt">Total expenses&#9;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">160,620.86</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><B>Item&nbsp;15. Indemnification of Directors and Officers. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Section&nbsp;102 of the DGCL permits a corporation to eliminate the
personal liability of directors of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary
duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct
or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law
or obtained an improper personal benefit. Our Amended Charter provides that no director of the Registrant shall be personally liable to
it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing
such liability, except to the extent that the DGCL prohibits the elimination or limitation of liability of directors for breaches of fiduciary
duty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Section&nbsp;145 of the DGCL provides that a corporation has the
power to indemnify a director, officer, employee, or agent of the corporation, or a person serving at the request of the corporation for
another corporation, partnership, joint venture, trust or other enterprise in related capacities against expenses (including attorneys&#8217;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with an action, suit
or proceeding to which he was or is a party or is threatened to be made a party to any threatened, ending or completed action, suit or
proceeding by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed
to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his conduct was
unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect
to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the
extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all
of the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery
or such other court shall deem proper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Our Amended Charter provides that we will indemnify each person
who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding (other than
an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, a director or officer, or
is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or in a similar capacity
with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an &#8220;Indemnitee&#8221;),
or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees),
judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and
any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to,
our best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct
was unlawful. Our Amended Charter provides that we will indemnify any Indemnitee who was or is a party to an action or suit by or in
the right of us to procure a judgment in our favor by reason of the fact that the Indemnitee is or was, or has agreed to become, a director
or officer, or is or was serving, or has agreed to serve, at our request as a director, officer, partner, employee or trustee of, or
in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged
to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent permitted by
law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom,
if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, our best interests,
except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged
to be liable to us, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled
to indemnification of such expenses.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits
or otherwise, he or she will be indemnified by us against all expenses (including attorneys&#8217; fees) actually and reasonably incurred
in connection therewith. Expenses must be advanced to an Indemnitee under certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We have entered into indemnification agreements with each of our
directors and officers. These indemnification agreements may require us, among other things, to indemnify our directors and officers for
some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by a director or officer in any action
or proceeding arising out of his or her service as one of our directors or officers, or any of our subsidiaries or any other company or
enterprise to which the person provides services at our request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We maintain a general liability insurance policy that covers certain
liabilities of directors and officers of our corporation arising out of claims based on acts or omissions in their capacities as directors
or officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">In any underwriting agreement we enter into in connection with the
sale of Common Stock being registered hereby, the underwriters will agree to indemnify, under certain conditions, us, our directors, our
officers and persons who control us within the meaning of the Securities Act against certain liabilities.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Item&nbsp;16.</B></TD><TD><B>Exhibits and Financial Statement Schedules. </B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(a)</TD><TD><B>Exhibits.</B></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 67%">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 7%; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-left: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="white-space: nowrap">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><B>Exhibit</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD ROWSPAN="2">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 0.15in; text-align: center"><B>Description</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 0in 1pt 0.15in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD COLSPAN="3" STYLE="padding-left: 5pt">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Incorporated by Reference</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Form</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Exhibit</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 5pt">
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0 4pt 0 0; text-align: center"><B>Filing<BR>
    Date</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin: 1pt 4pt 1pt 0in"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">2.1*&#8224;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000121390021025902/fs42021_cffinanceacq3.htm">Merger Agreement, dated as of February&nbsp;17, 2021, by and among the Company, Merger Sub and AEye Technologies</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">S-4</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">5/13/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">2.2*&#8224;</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000121390021025902/fs42021_cffinanceacq3.htm">Amendment to the Merger Agreement, dated as of April&nbsp; 30, 2021, by and among the Company, Merger Sub and AEye Technologies</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">S-4</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">2.2</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">5/13/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">3.1*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000119312521253301/d188241dex31.htm">Second Amended and Restated Certificate of Incorporation of AEye, Inc.</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">8/23/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">3.2*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000119312521253301/d188241dex32.htm">Amended and Restated Bylaws of AEye, Inc.</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">8/23/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">4.1*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000094787121001285/ss682453_ex0401.htm">Registration Rights Agreement by and between AEye, Inc. and Tumim Stone Capital LLC, dated December&nbsp;8, 2021</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">8-K/A</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">12/15/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">4.2*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000121390020038048/ea130122ex4-1_cffinanceacq3.htm">Warrant Agreement dated November&nbsp;12, 2020, between Continental Stock Transfer&nbsp; &amp; Trust Company and CF Finance Acquisition Corp. III</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">S-4</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">5/13/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt; text-align: right">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">4.3*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000121390020032611/ea128663ex4-3_cffinanceacq.htm">Specimen Warrant Certificate</A> </FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">S-4</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; padding-bottom: 1pt; padding-left: 5pt; text-align: right"><FONT STYLE="font-size: 10pt">5/13/2021</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">5.1#</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="ss1352954_ex0501.htm">Opinion of Shearman&nbsp;&amp; Sterling LLP</A> </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">23.1#</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="ss1352954_ex2301.htm">Consent of Deloitte&nbsp;&amp; Touche LLP (with respect to AEye, Inc. financial statements)</A> </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 4pt; padding-left: 5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 0.1in"><FONT STYLE="font-size: 10pt">23.2#</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="ss1352954_ex0501.htm">Consent of Shearman&nbsp;&amp; Sterling LLP (included in Exhibit 5.1)</A> </FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; padding-right: 4pt; padding-left: 5pt; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 9pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top; padding-left: 9pt"><FONT STYLE="font-size: 10pt">24.1*</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0.15in"><FONT STYLE="font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1818644/000119312522142543/d295535ds1.htm#power">Power of Attorney (included on signature page of the initial filing of this Registration Statement)</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">&#8224;</TD><TD>Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5), which the Registrant
agrees to furnish supplementally to the SEC upon its request.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">#</TD><TD>Filed Herewith.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">*</TD><TD>Previously filed.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0.25in; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.45pt">(b)</TD><TD><B>Financial Statement Schedules. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">Schedules not listed above have been omitted because the information
required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><B>Item&nbsp;17. Undertakings. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0">(a) The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 0.5in">(1) to file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 1in">(i)&nbsp;to include any prospectus required
by Section&nbsp;10(a)(3) of the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 1in">(ii)&nbsp;to reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in
the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change
in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration
statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 1in">(iii)&nbsp;to include any material information with respect to
the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement; provided, however, that paragraphs (i), (ii) and (iii)&nbsp;do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section&nbsp;13
or Section&nbsp;15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained
in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">(2) that, for the purpose of determining any liability under the
Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">(3) to remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of the offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">(4) that, for the purpose of determining liability under the Securities
Act to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(i) Each prospectus filed by the registrant pursuant
    to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and
    included in the registration statement; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 22.5pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">(ii) Each prospectus required to be filed pursuant
    to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant
    to Rule 415(a)(1)(i), (vii), or (x)&nbsp;for the purpose of providing the information required by section 10(a) of the Securities Act
    of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus
    is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus.
    As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be
    deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that
    prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided,
    however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
    incorporated or deemed incorporated by reference in the registration statement or prospectus that is part of the registration statement
    will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made
    in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior
    to such effective date; and</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">(5) that, for the purpose of determining liability of the registrant under
the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary
offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used
to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 1in">(i) any preliminary prospectus or prospectus
of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 1in">(ii) any free writing prospectus relating to
the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-indent: 1in">(iii) the portion of any other free writing
prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or
on behalf of an undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 1in">(iv) any other communication that is an offer
in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">(b) The undersigned registrant
hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s
annual report pursuant to Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an
employee benefit plan&rsquo;s annual report pursuant to Section&nbsp;15(d) of the Securities Exchange Act of 1934) that is incorporated
by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial&nbsp;<I>bona fide</I>&nbsp;offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">(h) Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy
as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed
in the Securities Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font-size: 10pt; margin: 0pt"><A HREF="#TableOfContents">Table of Contents</A>&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><A NAME="SIGNATURES" TITLE="SIGNATURES"></A>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, hereunto duly authorized, in Dublin,
California, on this 26th day of September, 2022.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 8%">&nbsp;</TD>
    <TD STYLE="width: 92%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>AEYE, INC.</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Blair LaCorte</FONT></TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="font: 12pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 13%">&nbsp;</TD>
    <TD STYLE="width: 87%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Blair LaCorte</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 12pt">Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 on Form S-3 has been signed below by the following persons in
the capacities and on the date indicated.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 48%">&nbsp;</TD>
    <TD STYLE="width: 18%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0"><B>Signature</B></P>
<!-- Field: Rule-Page --><DIV STYLE="width: 25%; margin-top: 1pt; margin-bottom: 1pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 0.1in">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Title</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD>
    <TD STYLE="padding-left: 0.1in">
    <P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Date</B></P>
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Chief Executive Officer and Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Blair LaCorte</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Robert Brown</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Principal Financial Officer and Principal <BR>
Accounting Officer)</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Board Chair and Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Carol DiBattiste</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Wen Hsieh</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Prof. Dr.&nbsp;Bernd Gottschalk</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Timothy J. Dunn</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Sue Zeifman</FONT></TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in; line-height: 2pt">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">September 26, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Luis Dussan</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 6pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 50%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 90%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">* By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">/s/ Blair LaCorte</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Blair LaCorte</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Attorney-in-fact</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">5</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ss1352954_ex0501.htm
<DESCRIPTION>OPINION OF SHEARMAN & STERLING LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.1 </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 11px; width: 230px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1460 El Camino Real</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2nd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Menlo Park, CA 94025-4110</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">+1.650.838.3600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: right">September 26, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">AEye, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">One Park Place, Suite 200</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dublin, CA 94568</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><U>AEye, Inc. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Registration Statement on Form S-3 </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We have acted as counsel to AEye, Inc., a Delaware corporation (the
&#8220;<U>Company</U>&#8221;), in connection with the preparation and filing by the Company of the Registration Statement on Form S-3
(the &#8220;<U>Registration Statement</U>&#8221;) with the Securities and Exchange Commission (the &#8220;<U>Commission</U>&#8221;) under
the Securities Act of 1933, as amended (the &#8220;<U>Securities Act</U>&#8221;), relating to the registration by the Company of the offer
and sale from time to time by the selling stockholder covered by the Registration Statement of 30,865,419 shares of common stock, par
value $0.0001, of the Company (&#8220;<U>Common Stock</U>&#8221;), of which (i) 302,634 shares (the &#8220;<U>Commitment Shares</U>&#8221;)
have been issued to Tumim Stone Capital LLC (&#8220;<U>Tumim</U>&#8221;) and (ii) 30,562,785 shares (the &#8220;<U>Purchase Shares</U>&#8221;
and together with the Commitment Shares, the &#8220;<U>Shares</U>&#8221;) have been reserved for issuance pursuant to a common stock purchase
agreement between the Company and Tumim, dated as of December&nbsp;8, 2021 (the &#8220;<U>Purchase Agreement</U>&#8221;), as described
in the prospectus forming a part of the Registration Statement (the &#8220;<U>Prospectus</U>&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">In rendering the opinions expressed below, we have reviewed originals
or copies of the following documents (the &#8220;<U>Opinion Documents</U>&#8221;):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(a)</TD><TD>The Second Amended and Restated Certificate of Incorporation and the Amended and Restated Bylaws of the Company, in each case, as
amended through the date hereof (the &#8220;<U>Governing Documents</U>&#8221;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(b)</TD><TD>The Registration Statement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(c)</TD><TD>The Prospectus; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(d)</TD><TD>Such other corporate records of the Company, certificates of public officials and of officers of the Company and agreements and other
documents as we have deemed necessary as a basis for the opinion expressed below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 24.5pt">In our review of the Opinion Documents, we
have assumed:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(a)</TD><TD>The genuineness of all signatures;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(b)</TD><TD>The authenticity of the originals of the documents submitted to us;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(c)</TD><TD>The conformity to authentic originals of any documents submitted to us as copies; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">(d)</TD><TD>As to matters of fact, the truthfulness of the representations made in the Opinion Documents, and in certificates of public officials
and officers of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We have not independently established the validity of the foregoing
assumptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Based upon the foregoing and upon such other investigation as we
have deemed necessary and subject to the qualifications set forth below, we are of the opinion that:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>SHEARMAN.COM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Shearman &amp; Sterling LLP is a limited liability partnership organized
in the United States under the laws of the state of Delaware, which laws limit the personal liability of partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR STYLE="clear: both">
Page 2</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">1.</TD><TD>the Commitment Shares have been duly authorized by the Company and are validly issued, fully paid and non-assessable; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 30.55pt"></TD><TD STYLE="width: 24.5pt">2.</TD><TD>the Purchase Shares have been duly authorized by the Company, and when issued and delivered by the Company pursuant to the Purchase
Agreement in the manner described in the Registration Statement and the Prospectus, and in accordance with the resolutions adopted by
the Board of Directors of the Company, will be validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This opinion letter is limited to the General Corporation Law of
the State of Delaware and we do not express any opinion herein concerning any other law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This opinion letter is delivered to you in connection with the filing
of the Registration Statement. This opinion letter may not be relied upon by you for any other purpose without our prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">This opinion letter speaks only as of the date hereof. We expressly
disclaim any responsibility to advise you of any development or circumstance of any kind, including any change of law or fact, that may
occur after the date of this opinion letter and which might affect the opinions expressed herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We hereby consent to the filing of this opinion letter as an exhibit
to the Registration Statement and to the use of our name therein and in the Prospectus under the caption &#8220;Legal Matters.&#8221;
In giving this consent, we do not hereby admit that we come within the category of persons whose consent is required under Section&nbsp;7
of the Securities Act, or the rules and regulations of the Commission promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ Shearman&nbsp;&amp; Sterling LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">CMF/an</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">YH</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ss1352954_ex2301.htm
<DESCRIPTION>CONSENT OF DELOITTE & TOUCHE LLP
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 23.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">We consent to the incorporation by reference in this Registration
Statement No. 333-264727 on Form S-3 of our report dated March&nbsp;28, 2022 relating to the financial statements of AEye, Inc., appearing
in the Annual Report on Form 10-K of AEye, Inc. for the year ended December 31, 2021. We also consent to the reference to us under the
heading &#8220;Experts&#8221; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><I>/s/ DELOITTE&nbsp;&amp; TOUCHE LLP </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">San Francisco, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">September 26, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  . 1\# 2(  A$! Q$!_\0
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<2!BM7PGI-I9^']/>&V@CG^S(&D1 &/'/- '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
